About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
1324 genotypes with 1823 annotations displayed of selected term and subterms
Searched Term: autoimmune response
Allelic Composition
(Genetic Background)
Annotated Term Reference
1700016L21RikTg(Itgax-DTR/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/Jdk)
decreased susceptibility to autoimmune diabetes J:137009
Acantm2Afos/Acantm2Afos
(involves: C57BL/6)
decreased susceptibility to induced arthritis J:122102
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
increased susceptibility to experimental autoimmune encephalomyelitis J:166490
Acla1BXSB/Slc/Acla1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc)
increased autoantibody level J:49899
Acla1NZW/Slc/Acla1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc)
increased autoantibody level J:49899
Acla2BXSB/Slc/Acla2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc)
increased autoantibody level J:49899
Acla2NZW/Slc/Acla2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc)
increased autoantibody level J:49899
Actbtm4(cre/ERT2)Npa/Actb+
Sgpl1tm1.1Npa/Sgpl1tm1.1Npa

(involves: BALB/cJ * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:199525
Adam8tm1.1Mdz/Adam8tm1.1Mdz
(DBA/1LacJ-Adam8tm1.1Mdz)
decreased susceptibility to induced arthritis J:155243
Adamts5tm1.1Eam/Adamts5+
(involves: 129S5/SvEvBrd)
decreased susceptibility to induced arthritis J:97590
Adamts5tm1.1Eam/Adamts5tm1.1Eam
(involves: 129S5/SvEvBrd)
decreased susceptibility to induced arthritis J:97590
Adamts5tm2.2Lex/Adamts5tm2.2Lex
(B6.129S5-Adamts5tm2.2Lex)
decreased susceptibility to induced arthritis J:175366
Adaz1NZM2328/J/Adaz1NZM2328/J
(involves: C57L/J * NZM2328/J)
increased anti-double stranded DNA antibody level J:71397
Adgrd1tm1b(EUCOMM)Wtsi/Adgrd1tm1b(EUCOMM)Wtsi
(C57BL/6N-Adgrd1tm1b(EUCOMM)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Ads1NZB/Ads1NZB
(involves: NZB * NZW)
increased anti-double stranded DNA antibody level J:7239, J:7111
increased susceptibility to autoimmune disorder J:7111
Ads1NZB/Ads1NZW
(involves: NZB * NZW)
increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
Ads2NZB/Ads2NZB
(involves: NZB * NZW)
increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
Ads2NZB/Ads2NZW
(involves: NZB * NZW)
increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
Ads3NZB/Ads3NZW
(involves: NZB * NZW)
increased susceptibility to autoimmune disorder J:7111
Ads3NZW/Ads3NZW
(involves: NZB * NZW)
increased anti-double stranded DNA antibody level J:7239
increased susceptibility to autoimmune disorder J:7111
Ads4NZB/Ads4NZB
(involves: NZB * NZW)
decreased anti-double stranded DNA antibody level J:11074
Ads4NZB/Ads4NZW
(involves: NZB * NZW)
increased susceptibility to autoimmune disorder J:7111
Ads4NZW/Ads4NZW
(involves: NZB * NZW)
increased susceptibility to autoimmune disorder J:7111
Aec1NOD/Uf/Aec1NOD/Uf
Aec2NOD/Uf/Aec2NOD/Uf

(B6.NOD-Aec2NOD/Uf Aec1NOD/Uf)
increased anti-nuclear antigen antibody level J:129282
increased susceptibility to autoimmune disorder J:128900
Aem1C57BL/6/Aem1NZB
(involves: C57BL/6 * NZB)
decreased autoantibody level J:7191
Aem2C57BL/6/Aem2C57BL/6
(involves: C57BL/6 * NZB)
decreased autoantibody level J:59427
Aem2C57BL/6/Aem2NZB
(involves: C57BL/6 * NZB)
decreased autoantibody level J:59427
Aem2C57BL/6/Aem2NZB
Aem3C57BL/6/Aem3NZB

(involves: C57BL/6 * NZB)
decreased autoantibody level J:59427
Agnm1MRL/MpJ/Agnm1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
increased susceptibility to systemic lupus erythematosus J:97786
Agnm2C3H/HeJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
increased susceptibility to systemic lupus erythematosus J:97786
Agnm2MRL/MpJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
increased susceptibility to systemic lupus erythematosus J:97786
Agnm3C3H/HeJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
increased susceptibility to systemic lupus erythematosus J:97786
Agnm3MRL/MpJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr)
increased susceptibility to systemic lupus erythematosus J:97786
Aia1NZB/Omr/Aia1NZB/Omr
(involves: NZB/Omr * NZC/Omr)
increased susceptibility to autoimmune hemolytic anemia J:6517
Aia1NZB/Omr/Aia1NZC/Omr
(involves: NZB/Omr * NZC/Omr)
increased susceptibility to autoimmune hemolytic anemia J:6517
Aif1tm1Nsib/Aif1tm1Nsib
(involves: 129S/SvEv * C57BL/6)
decreased susceptibility to induced arthritis J:204462
Aim2tm1.2Arte/Aim2tm1.2Arte
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt

(involves: 129 * BALB/c * C57BL/6 * C57BL/6J)
increased autoantibody level J:238323
rheumatoid arthritis J:238323
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6)
increased autoantibody level J:119475
increased susceptibility to autoimmune disorder J:83422
Airetm1.1Doi/Airetm1.1Doi
(B6.129S2-Airetm1.1Doi/Doi)
increased autoantibody level J:107432
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi)
increased autoantibody level J:107432
Airetm1.1Doi/Airetm1.1Doi
(C.129S2-Airetm1.1Doi/Doi)
increased autoantibody level J:107432
Airetm1.1Doi/Airetm1.1Doi
(SJL.129S2-Airetm1.1Doi/Doi)
increased autoantibody level J:107432
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand)
increased autoantibody level J:188686
increased susceptibility to autoimmune diabetes J:135154, J:188686
Airetm1Mmat/Airetm1Mmat
(involves: C57BL/6 * CBA)
autoimmune response J:96580
Airetm1Mmat/Airetm1Mmat
(C.Cg-Airetm1Mmat)
increased autoantibody level J:96580
Airetm1Mmat/Airetm1Mmat
(B6.Cg-Airetm1Mmat)
autoimmune response J:96580
Airetm1Mmat/Airetm2Mmat
(involves: C57BL/6 * CBA)
autoimmune response J:141379
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
increased autoantibody level J:77873
Airetm1Ptsn/Airetm1Ptsn
(C57BL/6-Airetm1Ptsn)
increased autoantibody level J:145910
Airetm1Ptsn/Airetm1Ptsn
(C.B6-Airetm1Ptsn)
increased susceptibility to autoimmune disorder J:174653
Airetm2Mmat/Airetm2Mmat
(involves: C57BL/6 * CBA)
autoimmune response J:141379
Alox5tm1Fun/Alox5tm1Fun
(B6.129S2-Alox5tm1Fun/J)
decreased susceptibility to experimental autoimmune uveoretinitis J:108446
Alox5aptm1Jdm/Alox5ap+
(DBA/1LacJ-Alox5aptm1Jdm)
decreased susceptibility to induced arthritis J:100736
Alox5aptm1Jdm/Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm)
decreased susceptibility to induced arthritis J:100736
anan/anan
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
increased anti-nuclear antigen antibody level J:169366
anan/anan+
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
increased anti-nuclear antigen antibody level J:169366
anaya/anaya
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
increased anti-nuclear antigen antibody level J:169366
andra/andra
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
increased anti-nuclear antigen antibody level J:169366
Anta/Anta+
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
increased anti-nuclear antigen antibody level J:169366
Apcstm1Mpe/Apcs+
(B6.Cg-Apcstm1Mpe)
increased autoantibody level J:90502
Apcstm1Mpe/Apcstm1Mpe
(B6.Cg-Apcstm1Mpe)
increased autoantibody level J:90502
Apcstm1Smae/Apcstm1Smae
(involves: 129S/SvEv * C57BL/6)
increased autoantibody level J:71194
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased autoantibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
Apoetm1Unc/Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr)
increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr

(MRL.Cg-Apoetm1Unc Faslpr)
increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased autoantibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr

(B6.Cg-Apoetm1Unc Faslpr)
decreased autoantibody level J:121671
increased anti-double stranded DNA antibody level J:121671
increased autoantibody level J:121671
Apoetm1Unc/Apoetm1Unc
Faslgld/Faslgld

(B6.Cg-Faslgld Apoetm1Unc)
increased anti-nuclear antigen antibody level J:200141, J:91058
increased autoantibody level J:91058
Arid5atm1Rnis/Arid5atm1Rnis
(B6.Cg-Arid5atm1Rnis)
decreased susceptibility to experimental autoimmune encephalomyelitis J:197418
Arigg1NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg2NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg3NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg4NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg5NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg6NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg7NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg8BALB/cByJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg9NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Arigg10BALB/cByJ/?
(involves: BALB/cByJ * NZB/BlNJ)
increased anti-erythrocyte antigen antibody level J:93737
Art2atm1Fkn/Art2atm1Fkn
Art2btm1Fkn/Art2btm1Fkn
Cd38tm1Lnd/Cd38tm1Lnd

(NOD.129(B6)-Cd38tm1Lnd Art2atm1Fkn Art2btm1Fkn/Lt)
decreased susceptibility to autoimmune diabetes J:108097
asa/asa
(either: A/J or BALB/c or DBA/2J)
increased autoantibody level J:2843
Asbb1BALB/c/Asbb1BALB/c
(involves: BALB/c * C57BL/6J)
increased susceptibility to systemic lupus erythematosus J:76486
Asbb2BALB/c/Asbb2C57BL/6J
(involves: BALB/c * C57BL/6J)
increased susceptibility to systemic lupus erythematosus J:76486
Asbb2C57BL/6J/Asbb2C57BL/6J
(involves: BALB/c * C57BL/6J)
increased susceptibility to systemic lupus erythematosus J:76486
Asbb3C57BL/6J/Asbb3C57BL/6J
(involves: BALB/c * C57BL/6J)
increased susceptibility to systemic lupus erythematosus J:76486
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu)
increased autoantibody level J:208213
increased susceptibility to autoimmune disorder J:208213
increased susceptibility to induced arthritis J:208213
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
Il6tm1Kopf/Il6tm1Kopf

(B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf)
increased susceptibility to induced arthritis J:208213
Atg5tm1Myok/Atg5tm1Myok
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129S/SvEv)
increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Atg7tm1Tchi/Atg7tm1Tchi
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Atxn3tm1a(KOMP)Wtsi/Atxn3tm1a(KOMP)Wtsi
(C57BL/6N-Atxn3tm1a(KOMP)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Aviltm2(cre)Fawa/Aviltm2(cre)Fawa
(B6J.129P2-Aviltm2(cre)Fawa)
increased susceptibility to experimental autoimmune encephalomyelitis J:265529
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl

(involves: C57BL/6J)
increased anti-double stranded DNA antibody level J:70420
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
abnormal susceptibility to autoimmune disorder J:70420
increased anti-double stranded DNA antibody level J:70420
increased autoantibody level J:70420
Axltm1Grl/Axltm1Grl
Tyro3tm1Grl/Tyro3tm1Grl

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
increased anti-double stranded DNA antibody level J:70420
B2mtm1Unc/B2mtm1Unc
(NOD.129P2-B2mtm1Unc)
decreased susceptibility to autoimmune diabetes J:121685, J:17000
B2mtm1Unc/B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ)
decreased susceptibility to autoimmune diabetes J:135214
B2mtm1Unc/B2mtm1Unc
Ciitatm1Ccum/Ciitatm1Ccum

(NOD.Cg-B2mtm1Unc Ciitatm1Ccum)
decreased susceptibility to autoimmune diabetes J:107051
B2mtm1Unc/B2mtm1Unc
Emv30b/Emv30b
Prkdcscid/Prkdcscid
Tg(B2M)55Hpl/?
Mcph1Tg(HLA-A2.1)1Enge/?

(NOD.Cg-B2mtm1Unc Mcph1Tg(HLA-A2.1)1Enge Emv30b Prkdcscid Tg(B2M)55Hpl/Dvs)
decreased susceptibility to autoimmune diabetes J:109851
B2mtm1Unc/B2mtm1Unc
Tg(B2M)55Hpl/0

(NOD.Cg-B2mtm1Unc Tg(B2M)55Hpl/Dvs)
decreased susceptibility to autoimmune diabetes J:71837
B2mtm1Unc/B2mtm1Unc
Tg(B2M)55Hpl/Tg(B2M)55Hpl
Mcph1Tg(HLA-A2.1)1Enge/Mcph1Tg(HLA-A2.1)1Enge

(NOD.Cg-B2mtm1Unc Mcph1Tg(HLA-A2.1)1Enge Tg(B2M)55Hpl)
increased susceptibility to autoimmune diabetes J:109851
B2mtm1Unc/B2mtm1Unc
Tg(GFAP-B2m)9Mdos/?

(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)
decreased susceptibility to autoimmune diabetes J:135214
B2mtm1Unc/B2mtm1Unc
Tg(GFAP-B2m)#Mdos/?

(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ)
decreased susceptibility to autoimmune diabetes J:135214
B2mtm1Unc/B2mtm1Unc
Tg(HLA-A/H2-D/B2M)1Dvs/0

(NOD.Cg-B2mtm1Unc Tg(HLA-A/H2-D/B2M)1Dvs)
increased susceptibility to autoimmune diabetes J:121685
B2mtm1Unc/B2mtm1Unc
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0

(NOD.Cg-B2mtm1Unc Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
decreased susceptibility to autoimmune diabetes J:93553
B2mtm1Unc/B2mtm1Unc
X/Yaa

(BXSB.129P2(B6)-B2mtm1Unc/Dcr)
increased anti-nuclear antigen antibody level J:179430
increased susceptibility to systemic lupus erythematosus J:179430
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0

(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
decreased susceptibility to experimental autoimmune encephalomyelitis J:123547
increased anti-double stranded DNA antibody level J:123547
increased anti-nuclear antigen antibody level J:123547
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tnfrsf4tm2(cre)Nik/Tnfrsf4+

(involves: 129S6/SvEvTac * 129X1/SvJ)
decreased susceptibility to experimental autoimmune encephalomyelitis J:169839
B9d2/Tgfb1tm1Flv/B9d2+
Tnfrsf4tm2(cre)Nik/Tnfrsf4+

(involves: 129S6/SvEvTac * 129X1/SvJ)
decreased susceptibility to experimental autoimmune encephalomyelitis J:169839
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Tg(Mx1-cre)1Cgn/0

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
increased anti-double stranded DNA antibody level J:100463
increased susceptibility to autoimmune disorder J:100463
Batftm1.1Kmm/Batftm1.1Kmm
(129S6/SvEvTac-Batftm1.1Kmm)
decreased susceptibility to experimental autoimmune encephalomyelitis J:150643
Bcl2l1tm1Cant/Bcl2l1tm1Cant
(involves: 129S6/SvEvTac)
decreased susceptibility to experimental autoimmune encephalomyelitis J:77507
Bcl2l11tm1.1Ast/Bcl2l11+
(involves: 129S1/Sv * C57BL/6)
increased susceptibility to autoimmune disorder J:58641
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
increased susceptibility to autoimmune disorder J:58641
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Faslpr/Faslpr

(B6.Cg-Bcl2l11tm1.1Ast Faslpr)
increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
increased susceptibility to autoimmune disorder J:132217
Becn1tm1.1Bflu/Becn1tm1.1Bflu
Tg(Cd4-cre)1Cwi/0

(involves: 129S1/Sv * C57BL/6 * DBA/2)
decreased susceptibility to experimental autoimmune encephalomyelitis J:203090
Becn1tm1Ebr/Becn1tm1Ebr
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd)
increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Bhlhe40tm1Tan/Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
abnormal susceptibility to autoimmune disorder J:72651
increased anti-nuclear antigen antibody level J:72651
Blnktm1Dkit/Blnktm1Dkit
(involves: C57BL/6)
increased anti-double stranded DNA antibody level J:94297
Bmxtm1Ali/Bmxtm1Ali
(involves: 129S1/Sv * 129X1/SvJ)
decreased susceptibility to induced arthritis J:173099
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas)
increased susceptibility to systemic lupus erythematosus J:287636
Btkxid/?
Ptpn6me/Ptpn6me

(involves: C57BL/6J * CBA/N * NFS)
increased autoantibody level J:30994
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:92639
Btkxid/Btkxid
(CBA/HN-Btkxid)
autoimmune response J:125114
Btlatm1Kmm/Btlatm1Kmm
(involves: 129S/SvEv)
increased susceptibility to experimental autoimmune encephalomyelitis J:84084
Btn2a2tm1.2Wrth/Btn2a2tm1.2Wrth
(C57BL/6-Btn2a2tm1.2Wrth)
increased anti-nuclear antigen antibody level J:232636
increased susceptibility to experimental autoimmune encephalomyelitis J:232636
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd)
autoimmune response J:145903
increased autoantibody level J:145903
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
(B10.BXSB-(D13Mit3-D13Mit78))
autoimmune response J:145049
increased anti-double stranded DNA antibody level J:145049
increased anti-single stranded DNA antibody level J:145049
increased autoantibody level J:145049
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
Gpab1C57BL/6J/?

(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd)
autoimmune response J:145903
increased autoantibody level J:145903
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
X/Yaa

(B10.BXSB-(D13Mit3-D13Mit78) Yaa)
autoimmune response J:145049
increased anti-double stranded DNA antibody level J:145049
increased anti-single stranded DNA antibody level J:145049
increased autoantibody level J:145049
C1qatm1Mjw/C1qatm1Mjw
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
increased anti-histone antibody level J:47315
increased anti-nuclear antigen antibody level J:47315
C1qatm1Mjw/C1qatm1Mjw
Sle16129S6/SvEvTac/Sle16129S6/SvEvTac

(involves: 129S/SvEv * 129X1/Sv * C57BL/6)
increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle16129S6/SvEvTac/Sle16C57BL/6

(involves: 129S/SvEv * 129X1/Sv * C57BL/6)
increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle18C57BL/6/Sle18C57BL/6

(involves: 129S/SvEv * 129X1/Sv * C57BL/6)
increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle18C57BL/6/Sle18C57BL/6

(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle19C57BL/6/?

(involves: 129S/SvEv * 129X1/Sv * C57BL/6)
increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle19C57BL/6/?

(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle21129P2/Ola/?
Sle18C57BL/6/Sle18C57BL/6

(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle21129P2/Ola/Sle21129P2/Ola

(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle21129P2/Ola/Sle21C57BL/6

(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qtnf3tm1Yiw/C1qtnf3tm1Yiw
(involves: C57BL/6NSlc)
increased susceptibility to induced arthritis J:211893
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
increased anti-nuclear antigen antibody level J:227217
increased autoantibody level J:227217
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw)
increased susceptibility to experimental autoimmune encephalomyelitis J:227217
increased susceptibility to induced arthritis J:227217
C3tm1Crr/C3tm1Crr
(B6.129S4-C3tm1Crr)
decreased susceptibility to autoimmune hemolytic anemia J:145432
C3tm1Crr/C3tm1Crr
C4btm1Crr/C4btm1Crr
Faslpr/Faslpr

(involves: 129S4/SvJae * C57BL/6 * MRL)
increased anti-double stranded DNA antibody level J:127292
increased anti-nuclear antigen antibody level J:127292
C3tm1Crr/C3tm1Crr
Faslpr/Faslpr

(involves: 129S4/SvJae * C57BL/6 * MRL)
decreased susceptibility to autoimmune disorder J:127292
C3tm1Crr/C3tm1Crr
Fcer1gtm1Rav/Fcer1gtm1Rav
Tg(Ins2-TFRC/OVA)296Wehi/0

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
decreased susceptibility to autoimmune diabetes J:122114
C3tm1Crr/C3tm1Crr
Tg(Ins2-TFRC/OVA)296Wehi/0

(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to autoimmune diabetes J:122114
C3tm1Pkna/C3tm1Pkna
(D1.129P2-C3tm1Pkna)
decreased susceptibility to induced arthritis J:88872
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
decreased susceptibility to experimental autoimmune encephalomyelitis J:93791
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6J)
increased anti-double stranded DNA antibody level J:111811
increased anti-nuclear antigen antibody level J:111811
increased anti-single stranded DNA antibody level J:111811
C4btm1Crr/C4btm1Crr
Faslpr/Faslpr

(involves: 129S4/SvJae * C57BL/6 * MRL)
increased anti-double stranded DNA antibody level J:127292
increased anti-nuclear antigen antibody level J:127292
C9orf72em1Eggn/C9orf72em1Eggn
(involves: C57BL/6)
increased anti-double stranded DNA antibody level J:240357
C9orf72tm1.1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N)
increased autoantibody level J:240357
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
increased anti-double stranded DNA antibody level J:240357
increased autoantibody level J:240357
increased susceptibility to autoimmune disorder J:240357
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
increased anti-double stranded DNA antibody level J:240357
increased susceptibility to autoimmune disorder J:240357
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del

(involves: 129S2/SvPas * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:57101
Cblbtm1Hua/Cblbtm1Hua
(B6.129P2-Cblbtm1Hua)
increased susceptibility to experimental autoimmune encephalomyelitis J:94685
Cblbtm1Hua/Cblbtm1Hua
Ubash3btm1Jni/Ubash3btm1Jni
Ubash3atm1Jni/Ubash3atm1Jni

(Not Specified)
increased susceptibility to experimental autoimmune encephalomyelitis J:89761
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
decreased susceptibility to experimental autoimmune encephalomyelitis J:68145
Ccl2tm1Rol/Ccl2tm1Rol
(SJL.129S4-Ccl2tm1Rol)
decreased susceptibility to experimental autoimmune encephalomyelitis J:68145
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:63952
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:75838
Ccr2tm2.1Ifc/Ccr2tm2.1Ifc
Cx3cr1tm1Litt/Cx3cr1+

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
decreased susceptibility to experimental autoimmune encephalomyelitis J:166664
Ccr2tm2.1Ifc/Ccr2tm2.1Ifc
Cx3cr1tm1Litt/Cx3cr1tm1Litt

(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
decreased susceptibility to experimental autoimmune encephalomyelitis J:166664
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:148286
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor)
increased susceptibility to autoimmune disorder J:110910
Ccr8tm1Lira/Ccr8tm1Lira
(involves: 129S/SvEv * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:118417
Cd1d1tm1Crw/Cd1d1tm1Crw
(B6.129S4-Cd1d1tm1Crw)
decreased susceptibility to induced arthritis J:99107
Cd1d1tm1Luc/Cd1d1tm1Luc
(B6.129S6-Cd1d1tm1Luc)
autoimmune response J:122245
Cd1d1tm1Luc/Cd1d1tm1Luc
(C.129S6-Cd1d1tm1Luc)
increased anti-double stranded DNA antibody level J:121187
increased anti-nuclear antigen antibody level J:121187
Cd1d1tm1Luc/Cd1d1tm1Luc
Cx3cr1tm1Litt/Cx3cr1tm1Litt

(B6.129-Cd1d1tm1Luc Cx3cr1tm1Litt)
increased susceptibility to experimental autoimmune encephalomyelitis J:129712
Cd4tm1(cre/ERT2)Thbu/Cd4+
Gfm1tm1c(EUCOMM)Wtsi/Gfm1tm1c(EUCOMM)Wtsi

(involves: C57BL/6 * C57BL/6N * SJL)
decreased susceptibility to experimental autoimmune encephalomyelitis J:302272
Cd4tm1Knw/Cd4tm1Knw
(NOD.Cg-Cd4tm1Knw)
decreased susceptibility to autoimmune diabetes J:93553
Cd4tm1Knw/Cd4tm1Knw
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0

(NOD.Cg-Cd4tm1Knw Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
increased susceptibility to autoimmune diabetes J:93553
Cd4tm1Mak/Cd4tm1Mak
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+

(B6.Cg-Cd4tm1Mak Igh-Jtm2(3H9-VDJ*)Mwg)
increased anti-double stranded DNA antibody level J:142389
Cd5tm1.1Chra/Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N)
decreased susceptibility to experimental autoimmune encephalomyelitis J:189919
Cd5tm1Cgn/Cd5tm1Cgn
(B6.129P2-Cd5tm1Cgn)
decreased susceptibility to experimental autoimmune encephalomyelitis J:189919
Cd8atm1Mak/Cd8atm1Mak
Il15tm1Imx/Il15tm1Imx
X/Yaa

(BXSB.Cg-Cd8atm1Mak Il15tm1Imx/Dcr)
increased anti-nuclear antigen antibody level J:179430
increased susceptibility to systemic lupus erythematosus J:179430
Cd8atm1Mak/Cd8atm1Mak
X/Yaa

(BXSB.129S2(B6)-Cd8atm1Mak/4Dcr)
increased susceptibility to systemic lupus erythematosus J:179430
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+

(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
increased anti-double stranded DNA antibody level J:147840
increased susceptibility to systemic lupus erythematosus J:147840
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+

(involves: 129/Sv * 129P2/OlaHsd * FVB/N)
increased susceptibility to systemic lupus erythematosus J:147840
Cd19tm1(cre)Cgn/Cd19+
Fastm1Ach/Fastm1Ach

(involves: 129P2/OlaHsd * BALB/c)
increased anti-nuclear antigen antibody level J:123556
Cd19tm1(cre)Cgn/Cd19+
Fastm1Cgn/Fastm1Cgn

(B6.Cg-Cd19tm1(cre)Cgn Fastm1Cgn)
increased anti-single stranded DNA antibody level J:114948
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(Cd74/MOG)Awai/Gt(ROSA)26Sor+

(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(Cd74/MOG)Awai/Gt(ROSA)26Sor+
Il10tm1Roer/Il10tm1Roer

(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
Cd19tm1(cre)Cgn/Cd19+
Ptpn6tm1Rsky/Ptpn6tm1Rsky

(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to systemic lupus erythematosus J:123568
Cd19tm1(cre)Cgn/Cd19+
Tnfaip3tm1.1Awai/Tnfaip3tm1.1Awai

(involves: 129P2/OlaHsd)
increased anti-nuclear antigen antibody level J:175422
Cd19tm1(cre)Cgn/Cd19+
Tnfaip3tm2Ama/Tnfaip3+

(involves: 129P2/OlaHsd * C57BL/6)
increased autoantibody level J:163917
increased susceptibility to autoimmune disorder J:163917
Cd19tm1Tft/Cd19tm1Tft
(B6.Cg-Cd19tm1Tft)
decreased anti-double stranded DNA antibody level J:136210
decreased anti-nuclear antigen antibody level J:136210
increased susceptibility to experimental autoimmune encephalomyelitis J:106487
Cd19tm1Tft/Cd19tm1Tft
Lyntm1Sor/Lyntm1Sor

(involves: 129S4/SvJaeSor * C57BL/6)
decreased anti-double stranded DNA antibody level J:71174
decreased susceptibility to systemic lupus erythematosus J:71174
Cd22tm1Msn/Cd22tm1Msn
(either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J))
increased anti-double stranded DNA antibody level J:76974, J:76975
Cd22tm2Lnit/Cd22tm2Lnit
(involves: 129P2/OlaHsd * C57BL/6)
autoimmune response J:198790
Cd22tm3Lnit/Cd22tm3Lnit
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
autoimmune response J:198790
Cd28tm1Jmg/Cd28tm1Jmg
(B6.129X1-Cd28tm1Jmg)
decreased susceptibility to experimental autoimmune encephalomyelitis J:149888
Cd28tm1Ltu/Cd28tm1Ltu
Foxp3tm4(YFP/icre)Ayr/Foxp3+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to autoimmune disorder J:194503
increased susceptibility to experimental autoimmune encephalomyelitis J:194503
Cd28tm1Mak/Cd28tm1Mak
(NOD.129S2-Cd28tm1Mak)
increased susceptibility to autoimmune diabetes J:93421
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * NOD)
increased susceptibility to autoimmune diabetes J:35353
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:149888
Cd28tm1Mak/Cd28tm1Mak
(B6.129S2-Cd28tm1Mak/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:57613
Cd28tm1Mak/Cd28tm1Mak
Cd40lgtm1Flv/Cd40lgtm1Flv

(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak)
increased susceptibility to autoimmune diabetes J:93421
Cd28tm1Shr/Cd28tm1Shr
Ctla4tm1Shr/Ctla4+

(C.129S4-Cd28tm1Shr Ctla4tm1Shr)
increased susceptibility to autoimmune disorder J:125259
Cd38tm1Lnd/Cd38tm1Lnd
(NOD.129P2(B6)-Cd38tm1Lnd/LtJ)
increased susceptibility to autoimmune diabetes J:108097
Cd40tm1Kik/Cd40tm1Kik
Tg(Tnfsf13b)1Fma/?

(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma)
increased anti-double stranded DNA antibody level J:113556
Cd40lgtm1Flv/Y
Faslpr/Faslpr

(involves: 129P2/OlaHsd * 129S2/SvPas * MRL)
decreased autoantibody level J:38492
Cd40lgtm1Flv/Y
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo

(involves: 129P2/OlaHsd * 129S2/SvPas * MRL)
decreased autoantibody level J:38492
increased anti-double stranded DNA antibody level J:38492
Cd40lgtm1Flv/Cd40lgtm1Flv
(NOD.129S2-Cd40lgtm1Flv)
decreased susceptibility to autoimmune diabetes J:93421
Cd40lgtm1Flv/Cd40lgtm1Flv
Faslpr/Faslpr

(involves: 129P2/OlaHsd * 129S2/SvPas * MRL)
decreased autoantibody level J:38492
Cd40lgtm1Flv/Cd40lgtm1Flv
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo

(involves: 129P2/OlaHsd * 129S2/SvPas * MRL)
decreased autoantibody level J:38492
increased anti-double stranded DNA antibody level J:38492
Cd44tm1.1Ugu/Cd44tm1.1Ugu
(B6.129(Cg)-Cd44tm1.1Ugu)
decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
Cd44tm1.1Ugu/Cd44tm1.1Ugu
(SJL.129(Cg)-Cd44tm1.1Ugu)
decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
Cd44tm1Mak/Cd44tm1Mak
(D1.129P2-Cd44tm1Mak)
increased susceptibility to induced arthritis J:95275
Cd44tm2.1Ugu/Cd44tm2.1Ugu
(B6.129-Cd44tm2.1Ugu)
decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
Cd44tm2Kmz/Cd44tm2Kmz
(DBA/1LacJ-Cd44tm2Kmz)
decreased susceptibility to induced arthritis J:74268
Cd55tm1Mme/Cd55tm1Mme
(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to experimental autoimmune myasthenia gravis J:80116
Cd55tm1Song/Cd55tm1Song
(B6.129S6-Cd55tm1Song)
increased susceptibility to experimental autoimmune myasthenia gravis J:113567
Cd55tm1Song/Cd55tm1Song
Cd59atm1Bpm/Cd59atm1Bpm

(B6.129-Cd55tm1Song Cd59atm1Bpm)
increased susceptibility to experimental autoimmune myasthenia gravis J:113567
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129 * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:89014
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129)
increased susceptibility to induced arthritis J:146711
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
increased susceptibility to experimental autoimmune myasthenia gravis J:113567
Cd69tm1Naka/Cd69tm1Naka
(C.129P2-Cd69tm1Naka)
decreased susceptibility to induced arthritis J:84940
Cd72b/Cd72b
Faslpr/Faslpr

(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
autoimmune response J:204782
decreased anti-double stranded DNA antibody level J:204782
decreased anti-nuclear antigen antibody level J:204782
decreased susceptibility to autoimmune disorder J:204782
Cd72c/Cd72c
Faslpr/Faslpr

(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
autoimmune response J:204782
increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
increased susceptibility to systemic lupus erythematosus J:204782
Cd72tm1Tsub/Cd72tm1Tsub
(involves: C57BL/6J)
increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
Cd72tm1Tsub/Cd72tm1Tsub
Faslpr/Faslpr

(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp)
autoimmune response J:204782
increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:72243
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz)
decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
Cd74tm2Liz/Cd74tm2Liz
(involves: 129S/SvEv * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:72243
Cd74tm3Liz/Cd74tm3Liz
(involves: 129S/SvEv * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:72243
Cd79atm1(cre)Reth/Cd79a+
Inpp5dtm1Rav/Inpp5dtm1Rav

(involves: 129 * BALB/c * C57BL/6)
increased anti-chromatin antibody level J:178833
increased anti-double stranded DNA antibody level J:178833
increased anti-nuclear antigen antibody level J:178833
increased anti-single stranded DNA antibody level J:178833
increased autoantibody level J:178833
increased susceptibility to systemic lupus erythematosus J:178833
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Y

(involves: BALB/c * C57BL/6)
increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Wastm1.1Ldn

(involves: BALB/c * C57BL/6)
increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
Cd79atm1.1Rsky/Cd79atm1.1Rsky
(involves: C57BL/6)
increased anti-single stranded DNA antibody level J:179254
Cd80tm1Shr/Cd80tm1Shr
Cd86tm1Shr/Cd86tm1Shr

(B6.129S4-Cd80tm1Shr Cd86tm1Shr)
decreased susceptibility to experimental autoimmune encephalomyelitis J:57613
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr

(involves: 129S4/SvJae)
increased susceptibility to autoimmune diabetes J:113109
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr

(involves: 129S4/SvJae * NOD)
increased susceptibility to autoimmune diabetes J:61905
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr

(129.SJL-Cd86tm2Shr)
decreased susceptibility to experimental autoimmune encephalomyelitis J:78992
increased susceptibility to experimental autoimmune encephalomyelitis J:78992
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr

(involves: 129S4/SvJae * C57BL/6J * SJL)
decreased susceptibility to experimental autoimmune encephalomyelitis J:78992
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0

(involves: 129S4/SvJae * FVB/N * NOD)
decreased susceptibility to autoimmune diabetes J:113109
Cd86tm1Shr/Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
decreased susceptibility to autoimmune diabetes J:71352
increased autoantibody level J:142046
increased susceptibility to autoimmune diabetes J:93421
Cd180tm1Kmiy/Cd180tm1Kmiy
Faslpr/Faslpr

(MRL.Cg-Cd180tm1Kmiy Faslpr)
increased anti-nuclear antigen antibody level J:137066
increased autoantibody level J:137066
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods)
increased susceptibility to experimental autoimmune encephalomyelitis J:65982
increased susceptibility to experimental autoimmune uveoretinitis J:79906
increased susceptibility to induced arthritis J:65982
Cd247tm2.1Lov/Cd247tm2.1Lov
(B6.Cg-Cd247tm2.1Lov)
increased susceptibility to experimental autoimmune encephalomyelitis J:192915
Cd274tm1.1Lex/Cd274tm1.1Lex
(involves: 129S5/SvEvBrd)
increased susceptibility to experimental autoimmune encephalomyelitis J:126829
Cd274tm1Lpc/Cd274tm1Lpc
(B6.129S-Cd274tm1Lpc)
increased susceptibility to autoimmune disorder J:89781
Cd274tm1Lpc/Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:142815
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc)
increased susceptibility to induced arthritis J:165841
Cd274tm1Shr/Cd274tm1Shr
(C.B6-Cd274tm1Shr)
increased susceptibility to autoimmune diabetes J:123785
Cd274tm1Shr/Cd274tm1Shr
Tg(TcraTcrb)1100Mjb/0

(involves: C57BL/6)
increased susceptibility to autoimmune diabetes J:153040
Cd276tm1Lpc/Cd276tm1Lpc
(B6.129-Cd276tm1Lpc)
decreased susceptibility to experimental autoimmune encephalomyelitis J:237700
Cd276tm1Lpc/Cd276tm1Lpc
(D1J.129-Cd276tm1Lpc)
decreased susceptibility to induced arthritis J:237700
Cd276tm1Mak/Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
increased anti-single stranded DNA antibody level J:84973
increased susceptibility to experimental autoimmune encephalomyelitis J:84973
Cd300lftm1Gne/Cd300lftm1Gne
(involves: C57BL/6N)
increased susceptibility to experimental autoimmune encephalomyelitis J:156819
Cdk2tm2Sgo/Cdk2tm2Sgo
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
Polr2atm1(cre/ERT2)Bbd/?

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
increased susceptibility to autoimmune diabetes J:125217
Cdk4tm1Kiyo/Cdk4+
Lin9tm1Orc/Lin9+

(involves: 129S1/Sv)
decreased susceptibility to autoimmune diabetes J:111333
Cdkn1atm1Led/Cdkn1atm1Led
(involves: 129S6/SvEvTac)
increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
Cdkn1atm1Led/Cdkn1atm1Led
Gadd45atm1Ajf/Gadd45atm1Ajf

(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6;129S2-Cdkn1atm1Tyj/J)
decreased susceptibility to induced arthritis J:108569
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
increased anti-double stranded DNA antibody level J:60292
increased anti-histone antibody level J:60292
increased anti-nuclear antigen antibody level J:60292
Ceat1CBA/J/Ceat1NOD
(involves: CBA/J * NOD-H2k)
increased susceptibility to experimental autoimmune thyroiditis J:77545
Ceat1NOD/Ceat1NOD
(involves: CBA/J * NOD-H2k)
increased susceptibility to experimental autoimmune thyroiditis J:77545
Cfbtm1Pkna/Cfbtm1Pkna
(D1.129P2-Cfbtm1Pkna)
decreased susceptibility to induced arthritis J:88872
Cfptm1Song/Cfptm1Song
(involves: 129 * C57BL/6)
decreased susceptibility to induced arthritis J:165497
Cfptm2.1Song/Cfptm2.1Song
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL)
decreased susceptibility to induced arthritis J:165497
Cgnz1NZM2328/J/Cgnz1NZM2328/J
(involves: C57L/J * NZM2328/J)
increased susceptibility to systemic lupus erythematosus J:71397
Chuktm2Mka/Chuktm2Mka
Tg(Tnfsf13b)1Fma/?

(B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma)
increased anti-double stranded DNA antibody level J:113556
Cia2DBA/1J/Cia2DBA/1J
(involves: DBA/1J * FVB/N)
increased susceptibility to induced arthritis J:116665
Cia5bRIIIS/J/?
(involves: C57BL/10 * RIIIS/J)
decreased susceptibility to induced arthritis J:101767
Cia5bRIIIS/J/Cia5bRIIIS/J
Cia32B10.RIII/Cia32RIIIS/J

(involves: C57BL/10 * RIIIS/J)
decreased susceptibility to induced arthritis J:101767
Cia5cRIIIS/J/?
(involves: C57BL/10 * RIIIS/J)
decreased susceptibility to induced arthritis J:101767
Cia7DBA/1J/Cia7DBA/1J
(involves: B10.Q * DBA/1)
increased susceptibility to induced arthritis J:122130
Cia30RIIIS/J/Cia30RIIIS/J
Cia5B10.RIII/Cia5B10.RIII

(involves: B10.RIII * RIIIS/J)
decreased susceptibility to induced arthritis J:95848
Cia31B10.RIII/Cia31RIIIS/J
Cia5RIIIS/J/Cia5RIIIS/J

(involves: C57BL/10 * RIIIS/J)
decreased susceptibility to induced arthritis J:101767
Cia34DBA/1J/Cia34DBA/1J
(involves: C57BL/10 * DBA/1J)
decreased autoantibody level J:122130
decreased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35C57BL/10SnSg
Cia42DBA/1J/Cia42DBA/1J

(involves: B10.Q * DBA/1)
decreased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35DBA/1J
(involves: C57BL/10 * DBA/1J)
increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35DBA/1J
Cia42DBA/1J/Cia42DBA/1J

(involves: B10.Q * DBA/1)
decreased susceptibility to induced arthritis J:122130
Cia35DBA/1J/Cia35DBA/1J
Cia42DBA/1J/Cia42DBA/1J

(involves: B10.Q * DBA/1)
decreased susceptibility to induced arthritis J:122130
Cia36DBA/1J/Cia36DBA/1J
(involves: C57BL/10 * DBA/1J)
decreased autoantibody level J:122130
decreased susceptibility to induced arthritis J:122130
Cia37C57BL/10SnSg/Cia37DBA/1J
(involves: C57BL/10 * DBA/1J)
increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
Cia38DBA/1J/Cia38DBA/1J
(involves: C57BL/10 * DBA/1J)
increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
Cia39C57BL/10Sn/Cia39C57BL/10Sn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r)
decreased susceptibility to induced arthritis J:97801
Cia40C57BL/10SnSg/Cia40C57BL/10SnSg
(involves: C57BL/10SnSg * DBA/1J * NFS/N)
increased susceptibility to induced arthritis J:106522
Cia43DBA/1J/Cia43FVB/N
(involves: DBA/1J * FVB/N)
increased susceptibility to induced arthritis J:146242
Cia43FVB/N/Cia43FVB/N
(involves: DBA/1J * FVB/N)
increased susceptibility to induced arthritis J:146242
Ciaaq1DBA/1J/Ciaaq1DBA/1J
(involves: DBA/1J * FVB/NJ)
increased autoantibody level J:122919
Ciaaq1DBA/1J/Ciaaq1FVB/NJ
(involves: DBA/1J * FVB/NJ)
increased autoantibody level J:122919
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
decreased susceptibility to autoimmune diabetes J:107051
Ciitatm1Jpyt/Ciitatm1Jpyt
(B6.129P2-Ciitatm1Jpyt)
decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
increased anti-nuclear antigen antibody level J:217720
increased autoantibody level J:217720
increased susceptibility to induced arthritis J:217720
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:203159
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ)
decreased susceptibility to experimental autoimmune encephalomyelitis J:203159
Clec5atm1Cua/Clec5atm1Cua
(involves: C57BL/6)
decreased susceptibility to induced arthritis J:158811
Cntftm1Mpin/Cntftm1Mpin
(B6.129S2-Cntftm1Mpin)
increased susceptibility to experimental autoimmune encephalomyelitis J:126852
Cog6tm1a(EUCOMM)Wtsi/Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Col17a1tm1Shzu/Col17a1tm1Shzu
Tg(KRT14-COL17A1)1Shzu/0

(involves: 129S/SvEv * C57BL/6J * C57BL/6Ncr)
decreased autoantibody level J:121695
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6)
increased autoantibody level J:220622
Coro1aLmb3-C57BL/6Scr/Coro1aLmb3-C57BL/6Scr
(MRL.Cg-Coro1aC57BL/6Scr Faslpr)
decreased autoantibody level J:125557
decreased susceptibility to systemic lupus erythematosus J:125557
Coro1aLmb3-MRL/MpScr/Coro1aLmb3-MRL/MpScr
(B6.MRL-Coro1aMRL/MpScr Faslpr)
increased susceptibility to systemic lupus erythematosus J:125557
Cr2tm1Crr/Cr2tm1Crr
(involves: 129S7/SvEvBrd * C57BL/6J)
increased anti-double stranded DNA antibody level J:111811
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:98419
Cry1tm1Jhjh/Cry1tm1Jhjh
Cry2tm1Jhjh/Cry2tm1Jhjh

(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to induced arthritis J:159504
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli

(B6.129S2-Csf2tm1Dran Il3tm1Glli)
increased anti-double stranded DNA antibody level J:83086
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas)
decreased susceptibility to experimental autoimmune encephalomyelitis J:148120
Csf3tm1Ard/Csf3tm1Ard
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0

(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
increased susceptibility to systemic lupus erythematosus J:155575
Ctla4tm1Saka/Ctla4tm1Saka
Foxp3tm1(cre)Saka/Y

(involves: BALB/c)
increased autoantibody level J:140085
Ctla4tm1Shr/Ctla4tm1Shr
(B6.129S4-Ctla4tm1Shr)
autoimmune response J:146644
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde)
decreased susceptibility to autoimmune diabetes J:153355
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde)
decreased susceptibility to autoimmune diabetes J:153355
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr)
decreased susceptibility to autoimmune diabetes J:153355
Ctsltm1Cptr/Ctsltm1Cptr
(NOD.129P2-Ctsltm1Cptr)
decreased susceptibility to autoimmune diabetes J:153355
Ctsstm1Eae/Ctsstm1Eae
(involves: C57BL/6 * DBA/1LacJ)
decreased susceptibility to induced arthritis J:53399
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae)
decreased susceptibility to autoimmune diabetes J:153355
Ctsstm1Hap/Ctsstm1Hap
(B6.129S2-Ctsstm1Hap)
decreased susceptibility to experimental autoimmune myasthenia gravis J:96401
Cx3cr1tm1Litt/Cx3cr1+
(B6.129P2-Cx3cr1tm1Litt)
increased susceptibility to experimental autoimmune encephalomyelitis J:129712
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
increased susceptibility to experimental autoimmune encephalomyelitis J:129712
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl)
increased susceptibility to experimental autoimmune encephalomyelitis J:87076
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J)
decreased susceptibility to induced arthritis J:142880
Cxcr4tm1Yiw/Cxcr4tm1Yiw
Tg(Lck-cre)1Jtak/0

(involves: 129P2/OlaHsd)
decreased susceptibility to induced arthritis J:164872
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
increased autoantibody level J:92438
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv)
increased anti-single stranded DNA antibody level J:216958
increased autoantibody level J:216958
increased susceptibility to autoimmune disorder J:216958
Cysltr2tm1Ykn/Cysltr2tm1Ykn
(C.B6-Cysltr2tm1Ykn)
autoimmune response J:182213
Cytl1tm1Chun/Cytl1tm1Chun
(involves: 129S4/SvJae * C57BL/6)
increased susceptibility to induced arthritis J:175377
DbaclC57BL/6Jcl/DbaclC57BL/6Jcl
(NOD.B6-(D4Mit193-D4Mit17))
increased susceptibility to autoimmune diabetes J:144964
Dcbld2tm1a(KOMP)Wtsi/Dcbld2tm1a(KOMP)Wtsi
(C57BL/6N-Dcbld2tm1a(KOMP)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Dclk1tm1a(EUCOMM)Wtsi/Dclk1+
(C57BL/6N-Dclk1tm1a(EUCOMM)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Dclk1tm1a(EUCOMM)Wtsi/Dclk1tm1a(EUCOMM)Wtsi
(C57BL/6N-Dclk1tm1a(EUCOMM)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Def6Gt(OST307148)Lex/Def6Gt(OST307148)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
increased anti-nuclear antigen antibody level J:106469
Del(1Aim2-Ifi205)1Stsn/+
Trex1tm1Tld/Trex1tm1Tld

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
increased autoantibody level J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
Trex1tm1Tld/Trex1tm1Tld

(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
increased autoantibody level J:234263
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw
Tg(TcraAV19AJ33)1Shima/0

(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:112657
Del(14Ltb4r2-Ltb4r1)1Bodd/+
(involves: 129S4/SvJaeSor * C57BL/6)
decreased susceptibility to induced arthritis J:131779
Del(14Ltb4r2-Ltb4r1)1Bodd/Del(14Ltb4r2-Ltb4r1)1Bodd
(involves: 129S4/SvJaeSor * C57BL/6)
decreased susceptibility to induced arthritis J:131779
Dffbem1(IMPC)Wtsi/Dffbem1(IMPC)Wtsi
(C57BL/6N-Dffbem1(IMPC)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
decreased susceptibility to induced arthritis J:293120
Dh/Dh+
H2d/H2d

(NZB.Cg-Dh)
increased anti-erythrocyte antigen antibody level J:12036
increased anti-nuclear antigen antibody level J:12036
increased anti-single stranded DNA antibody level J:12036
increased autoantibody level J:12036
Dicer1tm1Tara/Dicer1tm1Tara
Foxn1tm3(cre)Nrm/Foxn1+

(involves: 129P2/OlaHsd * C57BL/6NHsd)
increased susceptibility to induced arthritis J:180783
Dnase1tm1Tmo/Dnase1+
(involves: 129P2/OlaHsd * C57BL/6)
increased anti-nuclear antigen antibody level J:62549
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * C57BL/6)
increased anti-nuclear antigen antibody level J:62549
increased susceptibility to systemic lupus erythematosus J:62549
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * CD-1)
decreased susceptibility to systemic lupus erythematosus J:110060
Dnase1tm2092.1Arte/Dnase1tm2092.1Arte
(involves: C57BL/6)
increased anti-double stranded DNA antibody level J:277126
increased anti-histone antibody level J:277126
increased anti-nuclear antigen antibody level J:277126
increased autoantibody level J:277126
increased susceptibility to systemic lupus erythematosus J:277126
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
increased anti-double stranded DNA antibody level J:114982
increased autoantibody level J:238323
rheumatoid arthritis J:238323, J:114982
Dnase2atm1Osa/Dnase2atm2Osa
Tg(Mx1-cre)1Cgn/0

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA)
rheumatoid arthritis J:114982
Dntttm1Gfn/Dntttm1Gfn
Faslpr/Faslpr

(involves: 129S2/SvPas * C57BL/6 * MRL/MpJ)
decreased autoantibody level J:110248
Dock2m1Hsd/Dock2m1Hsd
Siaetm1.2Avrk/Siaetm1.2Avrk

(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd)
increased anti-double stranded DNA antibody level J:144035
increased anti-histone antibody level J:144035
increased anti-single stranded DNA antibody level J:144035
Dock8pri/Dock8pri
(involves: C57BL/6JAnu)
decreased susceptibility to experimental autoimmune encephalomyelitis J:238772
Dock10tm1Thar/Dock10tm1Thar
(involves: C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:300632
Dtx1tm1.1Mzl/Dtx1tm1.1Mzl
Tg(Cd4-cre)1Cwi/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
increased anti-double stranded DNA antibody level J:151605
increased anti-histone antibody level J:151605
increased autoantibody level J:151605
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
increased anti-double stranded DNA antibody level J:151605
increased anti-histone antibody level J:151605
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
increased susceptibility to induced arthritis J:126383
Dusp2tm1Cmac/Dusp2tm1Cmac
(B6.Cg-Dusp2tm1Cmac)
decreased susceptibility to induced arthritis J:112609
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac)
decreased susceptibility to experimental autoimmune encephalomyelitis J:92104
Dusp14Gt(OST210117)Lex/Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex)
increased susceptibility to experimental autoimmune encephalomyelitis J:209403
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht)
increased susceptibility to autoimmune disorder J:213253
increased susceptibility to experimental autoimmune encephalomyelitis J:213253
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
increased susceptibility to autoimmune diabetes J:93708
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
increased anti-double stranded DNA antibody level J:76318
increased susceptibility to autoimmune disorder J:76318
E2f2tm1Zubi/E2f2tm1Zubi
Tg(TcraH-Y,TcrbH-Y)71Vbo/?

(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
increased susceptibility to autoimmune disorder J:76318
Eae1A/J/Eae1A/J
(involves: A/J * C57BL/10SnJ)
increased susceptibility to experimental autoimmune encephalomyelitis J:30574
Eae1PL/J/Eae1PL/J
(involves: C57BL/10SnJ * PL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:30574
Eae2RIIIS/J/Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J)
decreased susceptibility to induced arthritis J:95848
Eae4ABH/?
(involves: ABH * NOD)
increased susceptibility to experimental autoimmune encephalomyelitis J:29171
Eae5B10.S/DvTe/Eae5SJL/J
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae5SJL/J/Eae5SJL/J
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae7B10.S/DvTe/Eae7B10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae7B10.S/DvTe/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae7SJL/J/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae9B10.S/DvTe/Eae9SJL/J
(involves: B10.S/DvTe * SJL/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae10SJL/J/Eae10SJL/J
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae11SJL/J/?
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:53193
Eae12SJL/J/Eae12SJL/J
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:53193
Eae13SJL/J/?
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:53193
Eae14C57BL/10/?
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:69083
Eae17SJL/J/?
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:69083
Eae18NOD/Eae18NOD
(involves: ABH * NOD)
decreased susceptibility to experimental autoimmune encephalomyelitis J:29171
Eae26B10.RIII/Eae26B10.RIII
(involves: B10.RIII * RIIIS/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:73850
Eae26B10.RIII/Eae26RIIIS/J
(involves: B10.RIII * RIIIS/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:73850
Eae33C57BL/10SnSg/?
(involves: B10.S * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:99793
Eae34C57BL/10SnSg/?
(involves: B10.S * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:99793
Eae35C57BL/10SnSg/?
(involves: B10.S * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:99793
Eae36SJL/J/?
(involves: B10.S * SJL/J)
increased susceptibility to autoimmune disorder J:99793
Eae37C57BL/10SnSg/?
(involves: B10.S * SJL/J)
increased susceptibility to autoimmune disorder J:99793
Eae38C57BL/10SnSg/?
(involves: B10.S * SJL/J)
increased susceptibility to autoimmune disorder J:99793
Eae42C57BL/10SnSg/?
(involves: B10.S * SJL/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:34892
Eae42SJL/J/?
(involves: B10.S * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:34892
Eae43B10.S/DvTe/?
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:53193
Eae43B10.S/DvTe/Eae43B10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae44aB10.S/DvTe/Eae44aB10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:56752
Eae44bB10.S/DvTe/Eae44bSJL/J
(involves: B10.S/DvTe * SJL/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:56752
Eae44bSJL/J/Eae44bSJL/J
(involves: B10.S/DvTe * SJL/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:56752
Ecm1tm1Bsun/Ecm1tm1Bsun
(involves: 129 * C57BL/6)
increased susceptibility to autoimmune disorder J:168252
Edil3Tg(lacZ)1Tq/Edil3Tg(lacZ)1Tq
(Not Specified)
increased susceptibility to induced arthritis J:254384
Elavl1tm1.1Atas/Elavl1tm1.1Atas
Tnfrsf4tm2(cre)Nik/Tnfrsf4+

(involves: 129X1/SvJ * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:207013
Endoutm1Tft/Endoutm1Tft
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0

(involves: 129S/SvEv * C57BL/6 * C57BL/6JSfd)
increased autoantibody level J:208364
Entpd7tm1Ktak/Entpd7tm1Ktak
(B6.Cg-Entpd7tm1Ktak)
increased susceptibility to experimental autoimmune encephalomyelitis J:191188
Ephb6tm1Jwu/Ephb6tm1Jwu
(involves: 129)
decreased susceptibility to experimental autoimmune encephalomyelitis J:94701
Erars1DBA/2J/?
(involves: BXD2/TyJ * C57BL/6J * DBA/2J)
increased anti-nuclear antigen antibody level J:96064
Ergtm1.1Iwamo/Ergtm1.1Iwamo
Tg(Gdf5-cre-ALPP)1Kng/?

(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
increased susceptibility to induced arthritis J:243715
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
increased anti-double stranded DNA antibody level J:88156
F2tm2Jld/F2+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)
decreased susceptibility to induced arthritis J:174629
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to induced arthritis J:81119
Faddtm1Mpa/Faddtm1Mpa
Mogtm1(cre)Gkl/Mog+

(involves: C57BL/6 * SJL)
decreased susceptibility to experimental autoimmune encephalomyelitis J:167475
Faslpr-cg/Faslpr-cg
(CBA/KlJms-Faslpr-cg/J)
autoimmune response J:24805, J:81770
increased anti-nuclear antigen antibody level J:24805
increased autoantibody level J:81770
Faslpr/Faslpr
(MRL/Mp-Faslpr)
increased anti-double stranded DNA antibody level J:27634, J:131138, J:6257
increased anti-erythrocyte antigen antibody level J:27634
increased anti-nuclear antigen antibody level J:27634, J:28885
increased anti-single stranded DNA antibody level J:27634
increased autoantibody level J:28885
increased susceptibility to autoimmune disorder J:108760
Faslpr/Faslpr
(NOD.MRL(B6)-Faslpr)
decreased susceptibility to autoimmune diabetes J:64051
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
increased anti-double stranded DNA antibody level J:92084, J:122315, J:7454
increased anti-nuclear antigen antibody level J:111811, J:92084, J:14151, J:7454
increased autoantibody level J:92084, J:14151
increased susceptibility to systemic lupus erythematosus J:92084
Faslpr/Faslpr
(NOD.MRL-Faslpr)
decreased susceptibility to autoimmune diabetes J:78679
Faslpr/Faslpr
(involves: C3H * MRL/Mp)
autoimmune response J:1060
increased anti-nuclear antigen antibody level J:34296
increased susceptibility to systemic lupus erythematosus J:34296
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
Faslpr/Faslpr
(MRL-Faslpr)
increased anti-double stranded DNA antibody level J:126261
increased anti-nuclear antigen antibody level J:126261
Faslpr/Faslpr
(MRL.Cg-Irf1tm1Mak Faslpr)
increased anti-double stranded DNA antibody level J:114771
Faslpr/Faslpr
(C3.MRL-Faslpr/J)
increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:7454
increased autoantibody level J:7454
Faslpr/Faslpr
(B6.MRL-Faslpr)
increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:6638, J:135036
increased autoantibody level J:135036, J:7454
Faslpr/Faslpr
(AK.MRL-Faslpr)
increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:7454
increased autoantibody level J:7454
Faslpr/Faslpr
(MRL/MpJ-Faslpr)
autoimmune response J:125114
increased anti-nuclear antigen antibody level J:137066
increased autoantibody level J:137066
Faslpr/Faslpr
(involves: C57BL/6 * MRL/Mp)
increased anti-double stranded DNA antibody level J:73396
increased anti-single stranded DNA antibody level J:73396
Faslpr/Faslpr
Fcer1gtm1Tks/Fcer1gtm1Tks

(MRL.Cg-Fcer1gtm1Tks Faslpr)
increased anti-double stranded DNA antibody level J:106188
Faslpr/Faslpr
Havcr1tm1Kuch/Havcr1tm1Kuch

(B6.Cg-Havcr1tm1Kuch Faslpr)
increased anti-double stranded DNA antibody level J:186484
increased autoantibody level J:186484
increased susceptibility to systemic lupus erythematosus J:186484
Faslpr/Faslpr
Hspa13tm1.1Smoc/Hspa13tm1.1Smoc
Cd19tm1(cre)Cgn/Cd19+

(involves: 129P2/OlaHsd * 129S * C57BL/6 * MRL/Mp)
decreased autoantibody level J:303927
decreased susceptibility to systemic lupus erythematosus J:303927
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt

(MRL.Cg-Ifnar1tm1Agt Faslpr)
increased anti-nuclear antigen antibody level J:92084
increased autoantibody level J:92084
increased susceptibility to systemic lupus erythematosus J:92084
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt
Ifngr1tm1Agt/Ifngr1tm1Agt

(MRL.Cg-Ifngr1tm1Agt Ifnar1tm1Agt Faslpr)
decreased anti-nuclear antigen antibody level J:92084
decreased autoantibody level J:92084
decreased susceptibility to systemic lupus erythematosus J:92084
increased susceptibility to systemic lupus erythematosus J:92084
Faslpr/Faslpr
Ifngtm1Ts/Ifng+

(MRL.Cg-Ifngtm1Ts Faslpr)
increased autoantibody level J:123834
Faslpr/Faslpr
Ifngtm1Ts/Ifngtm1Ts

(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
decreased anti-double stranded DNA antibody level J:39600
decreased anti-nuclear antigen antibody level J:39600
decreased autoantibody level J:39600
decreased susceptibility to systemic lupus erythematosus J:39600
Faslpr/Faslpr
Ifngr1tm1Agt/Ifngr1tm1Agt

(MRL.Cg-Ifngr1tm1Agt Faslpr)
decreased anti-nuclear antigen antibody level J:92084
decreased autoantibody level J:92084
decreased susceptibility to systemic lupus erythematosus J:92084
Faslpr/Faslpr
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+

(MRL.Cg-Faslpr Igh-Jtm2(3H9-VDJ*)Mwg)
increased anti-double stranded DNA antibody level J:131138
Faslpr/Faslpr
Ighmtm1Cgn/Ighmtm1Cgn

(involves: 129S2/SvPas * C57BL/6 * MRL/Mp)
increased autoantibody level J:119584
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn

(involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)
decreased anti-nuclear antigen antibody level J:39600
decreased susceptibility to systemic lupus erythematosus J:39600
Faslpr/Faslpr
Il27ratm1Mak/Il27ratm1Mak

(MRL.Cg-Il27ratm1Mak Faslpr)
decreased anti-double stranded DNA antibody level J:122148
decreased susceptibility to systemic lupus erythematosus J:122148
Faslpr/Faslpr
Irf1tm1Mak/Irf1+

(MRL.Cg-Irf1tm1Mak Faslpr)
increased anti-double stranded DNA antibody level J:114771
Faslpr/Faslpr
Irf1tm1Mak/Irf1tm1Mak

(MRL.Cg-Irf1tm1Mak Faslpr)
decreased anti-double stranded DNA antibody level J:114771
Faslpr/Faslpr
Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex

(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)
increased anti-double stranded DNA antibody level J:205951
increased anti-nuclear antigen antibody level J:205951
increased susceptibility to systemic lupus erythematosus J:205951
Faslpr/Faslpr
Pou2af1tm1Pmt/Pou2af1tm1Pmt

(involves: 129P2/OlaHsd * C57BL/6 * MRL)
autoimmune response J:125114
Faslpr/Faslpr
Sh2d1arpl/Sh2d1arpl

(MRL/Mp-Faslpr Sh2d1arpl)
increased anti-nuclear antigen antibody level J:126261
Faslpr/Faslpr
Spp1tm1Rit/Spp1tm1Rit

(involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp)
increased anti-double stranded DNA antibody level J:73396
increased anti-single stranded DNA antibody level J:73396
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo

(involves: 129P2/OlaHsd * 129S2/SvPas * MRL)
decreased autoantibody level J:38492
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0

(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
decreased susceptibility to systemic lupus erythematosus J:122222
increased anti-nuclear antigen antibody level J:122222
Faslpr/Faslpr
Tg(Ins2-Fasl)24Ach/0

(NOD.Cg-Faslpr Tg(Ins2-Fasl)24Ach)
decreased susceptibility to autoimmune diabetes J:81416
Faslpr/Faslpr
Tg(INS-Il10)#Sar/0

(NOD.Cg-Faslpr Tg(INS-Il10)#Sar)
increased susceptibility to autoimmune diabetes J:64051
Faslpr/Faslpr
Tlr7tm1Flv/Y

(involves: 129S1/Sv * C57BL/6 * MRL/Mp)
decreased autoantibody level J:113557
decreased susceptibility to systemic lupus erythematosus J:113557
increased anti-chromatin antibody level J:113557
increased autoantibody level J:113557
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki

(B6.Cg-Tlr9tm1Aki Faslpr)
autoimmune response J:135036
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki

(MRL.Cg-Tlr9tm1Aki Faslpr)
decreased autoantibody level J:113557
increased autoantibody level J:113557
increased susceptibility to systemic lupus erythematosus J:113557
Faslpr/Faslpr
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk

(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
increased anti-nuclear antigen antibody level J:127197
increased susceptibility to systemic lupus erythematosus J:127197
Fastheo/Fastheo
(either: (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd) or (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd * CBA/CaJAnu))
increased anti-nuclear antigen antibody level J:104190
Fastm1Ach/Fastm1Ach
Tg(GZMB-cre)1Jcb/?

(involves: C57BL/6 * FVB/N)
increased anti-nuclear antigen antibody level J:123556
Fastm1Ach/Fastm1Ach
Tg(Itgax-cre,-EGFP)4097Ach/?

(Not Specified)
increased anti-nuclear antigen antibody level J:123556
Fastm1Ach/Fastm1Ach
Tg(Lck-cre)548Jxm/?

(involves: C57BL/6 * CBA)
increased anti-nuclear antigen antibody level J:123556
Fastm1Cgn/Fastm1Cgn
Cd19tm1(cre)Cgn/Cd19+
Tg(Cd4-cre)1Cwi/0

(B6.Cg-Tg(Cd4-cre)1Cwi Cd19tm1(cre)Cgn Fastm1Cgn)
increased anti-single stranded DNA antibody level J:114948
Fastm1Cgn/Fastm1Cgn
Mogtm1(cre)Gkl/Mog+

(involves: C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
Fastm1Cgn/Fastm1Cgn
Mogtm1(cre)Gkl/Mog+
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak

(involves: 129S2/SvPas * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0

(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
increased anti-single stranded DNA antibody level J:114948
Fastm1Cgn/Fastm1Cgn
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak

(involves: 129S2/SvPas * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
Fastm1Osa/Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6)
increased anti-double stranded DNA antibody level J:32125
increased anti-single stranded DNA antibody level J:32125
increased autoantibody level J:32125
Fastm1Vbo/Fastm1Vbo
Tg(Ins2-cre)25Mgn/0
Tg(Ins2-HA)165Bri/0
Tg(Tcra/Tcrb)1Vbo/0

(Not Specified)
increased susceptibility to autoimmune diabetes J:85985
Faslgld/Faslgld
(C3H/HeJ-Faslgld/J)
increased anti-double stranded DNA antibody level J:7306
increased anti-nuclear antigen antibody level J:7306, J:29572
increased autoantibody level J:7306
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6)
increased anti-nuclear antigen antibody level J:153501
increased susceptibility to systemic lupus erythematosus J:153501
Faslgld/Faslgld
(B6.C3-Faslgld)
increased anti-nuclear antigen antibody level J:91058
increased autoantibody level J:91058
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
increased anti-double stranded DNA antibody level J:153501
increased anti-nuclear antigen antibody level J:153501
increased susceptibility to systemic lupus erythematosus J:153501
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6)
autoimmune response J:87990
Fbn1tm2.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
increased anti-nuclear antigen antibody level J:206074
increased autoantibody level J:206074
Fbn1tm3.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
increased anti-nuclear antigen antibody level J:206074
increased autoantibody level J:206074
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk)
increased autoantibody level J:21987, J:14166
Fbn1Tsk/Fbn1+
Il4ratm1Sz/Il4ra+

(involves: BALB/cJ * C57BL/6J * C57BL/10 * DBA/2)
increased autoantibody level J:68448
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:126520
Fcer1gtm1Rav/Fcer1gtm1Rav
Tg(Ins2-TFRC/OVA)296Wehi/0

(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to autoimmune diabetes J:122114
Fcer1gtm1Tks/Fcer1gtm1Tks
(C57BL/6-Fcer1gtm1Tks)
decreased susceptibility to autoimmune hemolytic anemia J:145432
Fcgr1tm1Jsv/Fcgr1tm1Jsv
(involves: 129P2/OlaHsd * BALB/c)
decreased susceptibility to autoimmune hemolytic anemia J:83995
decreased susceptibility to induced arthritis J:83995
Fcgr2btm1.2Jsv/Fcgr2b+
X/Yaa

(involves: C57BL/6 * FVB/N * SB/Le)
increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased susceptibility to systemic lupus erythematosus J:179175
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv
Sle16C57BL/6/Sle16C57BL/6

(involves: C57BL/6 * FVB/N)
increased susceptibility to induced arthritis J:179175
Fcgr2btm1Kgcs/Fcgr2b+
(involves: C57BL/6)
increased anti-chromatin antibody level J:190890
increased anti-double stranded DNA antibody level J:190890
increased susceptibility to induced arthritis J:190890
Fcgr2btm1Ttk/Fcgr2btm1.2Jsv
Sle21129P2/Ola/Sle21C57BL/6

(involves: 129P2/Ola * 129S4/SvJae * C57BL/6 * FVB/N)
increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
increased susceptibility to systemic lupus erythematosus J:179175
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(Not Specified)
increased susceptibility to induced arthritis J:106191
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Il17atm1Yiw/Il17atm1Yiw

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
decreased susceptibility to systemic lupus erythematosus J:191090
increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Pdcd1tm1Hon/Pdcd1tm1Hon

(involves: 129S2/SvPas * 129S4/SvJae * BALB/c)
increased autoantibody level J:207275
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Sle21129P2/Ola/Sle21129P2/Ola

(B6.129S4-Fcgr2btm1Ttk)
increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
increased autoantibody level J:179175
increased susceptibility to induced arthritis J:179175
increased susceptibility to systemic lupus erythematosus J:179175
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Tg(Ins2-TFRC/OVA)296Wehi/0

(involves: 129S4/SvJae * C57BL/6)
increased susceptibility to autoimmune diabetes J:122114
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Tlr7tm1Flv/Y
X/Yaa

(B6.Cg-Fcgr2btm1Ttk Tlr7tm1Flv Yaa)
autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
increased susceptibility to systemic lupus erythematosus J:127600
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2+

(involves: 129 * 129S4/SvJae * C57BL/6)
increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
increased autoantibody level J:191090
increased susceptibility to systemic lupus erythematosus J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn

(involves: 129 * 129S4/SvJae * C57BL/6)
decreased susceptibility to systemic lupus erythematosus J:191090
increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
increased autoantibody level J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
X/Yaa

(B6.Cg-Fcgr2btm1Ttk Yaa)
autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
increased susceptibility to systemic lupus erythematosus J:127600
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to autoimmune hemolytic anemia J:83995
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.129P2-Fcgr3tm1Jsv/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:126520
decreased susceptibility to induced arthritis J:106191
Fcgr3tm1Jsv/Fcgr3tm1Jsv
Sle21129P2/Ola/Sle21129P2/Ola

(B6.129P2-Fcgr3tm1Jsv)
increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
Fcgr4tm1.1Rav/Fcgr4tm1.1Rav
(involves: C57BL/6)
decreased susceptibility to induced arthritis J:167375
Fcmrtm1Ohno/Fcmrtm1Ohno
(B6.129-Fcmrtm1Ohno)
increased anti-chromatin antibody level J:190117
increased anti-double stranded DNA antibody level J:190117
Fcrlbtm1Pdb/Fcrlbtm1Pdb
(B6.129-Fcrlbtm1Pdb)
increased anti-nuclear antigen antibody level J:165408
Fen1tm3.1Bhsh/Fen1+
(Not Specified)
increased anti-double stranded DNA antibody level J:231218
increased anti-nuclear antigen antibody level J:231218
increased susceptibility to autoimmune disorder J:231218
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
increased anti-double stranded DNA antibody level J:231218
increased anti-nuclear antigen antibody level J:231218
increased susceptibility to autoimmune disorder J:231218
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6)
increased susceptibility to induced arthritis J:153951
Fgl1tm1b(EUCOMM)Hmgu/Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N)
increased anti-double stranded DNA antibody level J:269578
Flicrem1Doi/Flicrem1Doi
(NOD/ShiLtDoi-Flicrem1Doi)
decreased susceptibility to autoimmune diabetes J:241346
Foxo1tm1Flv/Foxo1tm1Flv
Tg(Cd4-cre)1Cwi/?

(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
increased anti-double stranded DNA antibody level J:147057
increased anti-nuclear antigen antibody level J:147057
Foxp3tm1(cre)Saka/Y
(involves: BALB/c)
increased autoantibody level J:140085
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ)
increased susceptibility to autoimmune disorder J:82560
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to autoimmune disorder J:117743
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to autoimmune disorder J:117743
Foxp3tm1Ayr/Y
Tg(Cd4-cre)1Cwi/0

(involves: C57BL/6 * DBA/2)
increased susceptibility to autoimmune disorder J:97029
Foxp3tm1Kuch/?
Il6tm1Kopf/Il6tm1Kopf

(involves: 129S2/SvPas * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:123352
Foxp3tm2.1(EGFP/cre)Shori/Y
Pdcd1tm1Hon/Pdcd1tm1Hon

(involves: 129 * 129S2/SvPas * C57BL/6)
increased susceptibility to autoimmune disorder J:234397
Foxp3tm2Flv/Y
(involves: C57BL/6)
increased autoantibody level J:118631
Foxp3tm3(DTR/GFP)Ayr/Foxp3+
Gpr174tm1Cys/Gpr174+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
Foxp3tm3(DTR/GFP)Ayr/Foxp3tm3(DTR/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to autoimmune disorder J:117743
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
Ikzf4tm1Djr/Ikzf4tm1Djr

(involves: 129S1/Sv * 129X1/SvJ)
increased susceptibility to experimental autoimmune encephalomyelitis J:294549
Foxp3tm8Ayr/Y
(B6.129-Foxp3tm8Ayr)
autoimmune response J:157377
Fpr2tm1Rjf/Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6)
increased susceptibility to induced arthritis J:159658
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA)
increased susceptibility to experimental autoimmune uveoretinitis J:99347
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
Gadd45btm1Flv/Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv)
increased susceptibility to experimental autoimmune encephalomyelitis J:118837
Gadd45btm1Flv/Gadd45btm1Flv
Gadd45gtm1Flv/Gadd45gtm1Flv

(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
increased anti-double stranded DNA antibody level J:118837
increased anti-histone antibody level J:118837
Gata1tm6Sho/Gata1tm6Sho
(C.129S1-Gata1tm6Sho)
autoimmune response J:182213
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c)
decreased susceptibility to autoimmune diabetes J:59132
Ghrhtm1Salv/Ghrhtm1Salv
(involves: 129 * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:177054
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit)
decreased susceptibility to experimental autoimmune encephalomyelitis J:85381
Gm614tm1.1Cya/Gm614tm1.1Cya
Ighg1tm1(cre)Cgn/Ighg1+

(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
decreased susceptibility to systemic lupus erythematosus J:307345
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Lck-cre)548Jxm/0

(involves: 129S1/Sv * C57BL/6 * CBA)
increased susceptibility to autoimmune diabetes J:149560
Gpr132tm1Witt/Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c)
increased anti-nuclear antigen antibody level J:69473
Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys)
decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
Gpr174tm1Cys/Gpr174+
(B6.129-Gpr174tm1Cys)
decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
Gpsm3Gt(IST12408A1)Tigm/Gpsm3Gt(IST12408A1)Tigm
(involves: C57BL/6N)
decreased susceptibility to induced arthritis J:193270
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6)
increased anti-nuclear antigen antibody level J:193993
Grk6tm1.1Mca/Grk6tm1.1Mca
(B6.129S4-Grk6tm1.1Mca)
increased anti-double stranded DNA antibody level J:225063
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Tg(Plp1-cre/ERT)3Pop/0

(involves: 129S/SvEv * C57BL/6 * DBA/2)
autoimmune response J:234435
Gt(ROSA)26Sortm1(Ptpn22*)Draw/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+

(involves: 129P2/OlaHsd * C57BL/6)
increased anti-double stranded DNA antibody level J:201448
increased autoantibody level J:201448
Gt(ROSA)26Sortm2.1(Cd74/MOG)Awai/Gt(ROSA)26Sor+
(involves: C57BL/6 * BALB/cJ)
decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
Tg(CD2-icre)4Kio/0

(involves: C57BL/6 * C57BL/10 * CBA/Ca)
increased anti-double stranded DNA antibody level J:133215
increased anti-single stranded DNA antibody level J:133215
Gvhd4DBA/2J/Gvhd4DBA/2J
(involves: C57BL/10 * DBA/2J)
increased anti-single stranded DNA antibody level J:66655
Gvhd4DBA/2J/Gvhd4DBA/2J
Gvhd5DBA/2J/Gvhd5DBA/2J

(involves: C57BL/10 * DBA/2J)
increased anti-single stranded DNA antibody level J:66655
Gvhd5DBA/2J/Gvhd5DBA/2J
(involves: C57BL/10 * DBA/2J)
increased anti-single stranded DNA antibody level J:66655
H2-Ab1bm12/H2-Ab1bm12
(B6(C)-H2-Ab1bm12/KhEgJ)
decreased susceptibility to autoimmune disorder J:100123
decreased susceptibility to experimental autoimmune myasthenia gravis J:100213
H2-Ab1bm12/H2-Ab1bm12
(NZB.B6(C)-H2-Ab1bm12)
autoimmune response J:4554
increased anti-double stranded DNA antibody level J:104189
increased anti-erythrocyte antigen antibody level J:4554
increased anti-single stranded DNA antibody level J:104189
H2-Ab1em1Dvs/H2-Ab1em1Dvs
H2-D1em5Dvs/H2-D1em5Dvs
H2-K1em1Dvs/H2-K1em1Dvs

(NOD/ShiLtDvs-H2-K1em1Dvs H2-Ab1em1Dvs H2-D1em5Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Rag1tm1Mom/Rag1tm1Mom
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell

(NOD.Cg-Rag1tm1Mom H2-Ab1tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
increased autoantibody level J:113267
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell

(NOD.Cg-H2-Ab1tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell)
autoimmune response J:87013, J:86540
decreased susceptibility to autoimmune disorder J:87013
increased autoantibody level J:113267
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell

(NOD.Cg-H2-Ab1tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell)
increased autoantibody level J:113509
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(HLA-DRB1)31Dmz/0
Tg(Ins2-CD80)3B7Flv/0

(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL)
decreased susceptibility to autoimmune diabetes J:68641
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(Ins2-CD80)3B7Flv/0

(B6.Cg-H2-Ab1tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv)
increased susceptibility to autoimmune diabetes J:59245
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(Ins2-CD80)3B7Flv/0

(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA)
increased susceptibility to autoimmune diabetes J:68641
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(HLA-DQA1,HLA-DQB1)70Myl/0

(NOD.Cg-H2-Ab1tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl)
increased autoantibody level J:88055
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(HLA-DQA1,HLA-DQB1)73Myl/0

(NOD.Cg-H2-Ab1tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl)
increased autoantibody level J:88055
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(HLA-DRB1)31Dmz/0
Tg(Ins2-CD80)3B7Flv/0

(involves: 129S2/SvPas * C57BL/6 * CBA * SJL)
decreased susceptibility to autoimmune diabetes J:68641
H2-Ab1tm1Gru/H2-Ab1tm1Gru
Tg(Ins2-CD80)3B7Flv/0

(involves: 129S2/SvPas * C57BL/6 * CBA)
decreased susceptibility to autoimmune diabetes J:68641
H2-Ab1tm1Wug/H2-Ab1tm1Wug
(involves: C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:204951
H2-Ab1tm1Wug/H2-Ab1tm1Wug
Cd19tm1(cre)Cgn/Cd19+

(involves: 129S2/SvPas * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:204951
H2-D1em1Dvs/H2-D1em1Dvs
(NOD/ShiLtDvs-H2-D1em1Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-D1em2Dvs/H2-D1em2Dvs
(NOD/ShiLtDvs-H2-D1em2Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-D1em3Dvs/H2-D1em3Dvs
(NOD/ShiLtDvs-H2-D1em3Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-D1em4Dvs/H2-D1em4Dvs
(NOD/ShiLtDvs-H2-D1em4Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-D1em5Dvs/H2-D1em5Dvs
H2-K1em1Dvs/H2-K1em1Dvs

(NOD/ShiLtDvs-H2-K1em1Dvs H2-D1em5Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-D1em5Dvs/H2-D1em5Dvs
H2-K1em1Dvs/H2-K1em1Dvs
Tg(HLA-A/H2-D/B2M)1Dvs/?

(NOD/ShiLtDvs-H2-K1em1Dvs H2-D1em5Dvs Tg(HLA-A/H2-D/B2M)1Dvs/Dvs)
autoimmune response J:257229
increased susceptibility to autoimmune diabetes J:257229
H2-D1em5Dvs/H2-D1em5Dvs
H2-K1em1Dvs/H2-K1em1Dvs
Tg(HLA-B39/H2-D/B2m)2Dvs/?

(NOD/ShiLtDvs-H2-K1em1Dvs H2-D1em5Dvs Tg(HLA-B39/H2-D/B2M)2Dvs/Dvs)
autoimmune response J:257229
increased susceptibility to autoimmune diabetes J:257229
H2-D1tm1Bpe/H2-D1tm1Bpe
H2-K1tm1Bpe/H2-K1tm1Bpe
X/Yaa

(BXSB.129P2(B6)-H2-K1tm1Bpe H2-D1tm1Bpe/Dcr)
increased susceptibility to systemic lupus erythematosus J:179430
H2-DMatm1Luc/H2-DMatm1Luc
(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:72243
H2-DMatm1Luc/H2-DMatm1Luc
(B6.129S4-H2-Dmatm1Luc)
decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
H2-K1em4Dvs/H2-K1em4Dvs
(NOD/ShiLtDvs-H2-K1em4Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-K1em5Dvs/H2-K1em5Dvs
(NOD/ShiLtDvs-H2-K1em5Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-K1em7Dvs/H2-K1em7Dvs
(NOD/ShiLtDvs-H2-K1em7Dvs/Dvs)
decreased susceptibility to autoimmune diabetes J:257229
H2-T23tm1Cant/H2-T23tm1Cant
(involves: 129S6/SvEvTac * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:89808
H2-T23tm2Cant/H2-T23tm2Cant
(B6.129S6-H2-T23tm2Cant)
decreased susceptibility to experimental autoimmune encephalomyelitis J:142087
H2-T23tm2Cant/H2-T23tm2Cant
Tg(Tcra2D2,Tcrb2D2)1Kuch/?

(involves: 129S6/SvEvTac)
increased susceptibility to experimental autoimmune encephalomyelitis J:142087
H2-T23tm3Cant/H2-T23tm3Cant
(B6.129S6-H2-T23tm3Cant)
increased susceptibility to experimental autoimmune encephalomyelitis J:142087
H2b/H2b
(NOD.B10SnJ-H2b)
decreased susceptibility to autoimmune diabetes J:14178
H2b/H2d
((C57BL/6 x DBA/2)F1)
increased autoantibody level J:106141
H2b/H2g7
(NOD.B10SnJ-H2b)
decreased susceptibility to autoimmune diabetes J:14178
H2b/H2g7
Tg(TcraR28,TcrbR28)KRNDim/0

(involves: C57BL/6 * NOD * SJL)
rheumatoid arthritis J:36815, J:275827
H2d/H2d
(DBA/2)
increased autoantibody level J:106141
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0

(involves: 129S2/SvPas * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:189816
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)loKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0

(involves: 129S2/SvPas * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:189816
H2g7/H2g7
Ins2tm1Jja/Ins2tm1Jja
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0

(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
increased susceptibility to autoimmune diabetes J:111874
H2g7/H2g7
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0

(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
increased susceptibility to autoimmune diabetes J:111874
H2g7/H2g7
Tg(Ins2-Vtcn1)#Xxz/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0

(involves: C57BL/6 * NOD * SJL)
decreased susceptibility to autoimmune diabetes J:177612
H2g7/H2g7
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0

(B6.NOD-(D17Mit21-D17Mit10) Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
increased susceptibility to autoimmune diabetes J:167508
H2g7/H2g7
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0

(B6.Cg-H2g7 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
decreased susceptibility to autoimmune diabetes J:86926
H2g7/H2g7
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0

(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
decreased susceptibility to autoimmune diabetes J:111874
H2g7/H2q
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0

(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
increased susceptibility to autoimmune diabetes J:111874
H2h2/H2g7
(NOD.Cg-H2h2)
decreased susceptibility to autoimmune diabetes J:14178
H2h2/H2h2
(NOD.Cg-H2h2)
decreased susceptibility to autoimmune diabetes J:14178
H2h4/H2g7
(NOD.Cg-H2h4)
decreased susceptibility to autoimmune diabetes J:14178
H2h4/H2h4
(NOD.Cg-H2h4)
decreased susceptibility to autoimmune diabetes J:14178
H2i5/H2g7
(NOD.Cg-H2i5)
decreased susceptibility to autoimmune diabetes J:14178
H2i5/H2i5
(NOD.Cg-H2i5)
decreased susceptibility to autoimmune diabetes J:14178
H2i7/H2g7
(NOD.Cg-H2i7)
decreased susceptibility to autoimmune diabetes J:14178
H2i7/H2i7
(NOD.Cg-H2i7)
decreased susceptibility to autoimmune diabetes J:14178
H2k/H2g7
(NOD.Cg-H2k)
decreased susceptibility to autoimmune diabetes J:14178
H2k/H2k
(NOD.Cg-H2k)
increased susceptibility to autoimmune diabetes J:14178
H2q/?
Ncf1m1J/Ncf1m1J

(B6.Cg-Ncf1m1J H2q)
decreased susceptibility to experimental autoimmune encephalomyelitis J:92437
increased susceptibility to experimental autoimmune encephalomyelitis J:92437
increased susceptibility to induced arthritis J:92437
rheumatoid arthritis J:92437
H2q/H2q
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0

(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
decreased susceptibility to autoimmune diabetes J:111874
H2u/H2u
Rag1tm1Mom/Rag1tm1Mom
Tg(Tcra19,Tcrb19)#Stl/0

(either: (involves: 129S7/SvEvBrd * C57BL/6 * PL/J) or (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/10 * PL/J))
increased susceptibility to autoimmune disorder J:19795
H2u/H2u
Tg(Tcra19,Tcrb19)#Stl/0

(either: (involves: C57BL/6 * PL/J) or (involves: C57BL/6 * C57BL/10 * PL/J))
increased susceptibility to autoimmune disorder J:19795
increased susceptibility to experimental autoimmune encephalomyelitis J:19795
H2u/H2u
Tg(TCRA)B1Jg/?
Tg(TCRB)C14Jg/?

(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)
increased autoantibody level J:92991
increased susceptibility to experimental autoimmune encephalomyelitis J:92991
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch)
autoimmune response J:186484
increased anti-double stranded DNA antibody level J:186484
Hc0/Hc0
Tg(TcrbBL17)1Lmor/0

(involves: DBA/1J * SWR/J)
decreased susceptibility to induced arthritis J:134111
Hc1/?
Tg(TcrbBL17)1Lmor/0

(involves: DBA/1J * SWR/J)
increased susceptibility to induced arthritis J:134111
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:148086
Hif1atm3Rsjo/Hif1atm3Rsjo
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
decreased susceptibility to induced arthritis J:107682
Hmox1tm1.1Gkl/Hmox1tm1.1Gkl
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:148498
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))
increased susceptibility to autoimmune disorder J:21316
Hrh3Eae8-r/?
(B10.S-H2s/SgMcdJ)
decreased susceptibility to experimental autoimmune encephalomyelitis J:34892
Hrh3Eae8-r/Hrh3Eae8-r
(involves: B10.S/DvTe * SJL/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
Hrh3Eae8-s/?
(involves: B10.S * SJL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Hrh3tm1Twl/Hrh3tm1Twl
(B6.129X1-Hrh3tm1Twl)
increased susceptibility to experimental autoimmune encephalomyelitis J:122269
Hspa13tm1.1Smoc/Hspa13tm1.1Smoc
Cd19tm1(cre)Cgn/Cd19+

(involves: 129P2/OlaHsd * 129S * C57BL/6)
decreased autoantibody level J:303927
Ica1tm1Mdos/Ica1tm1Mdos
(NOD.129-Ica1tm1Mdos)
decreased susceptibility to autoimmune diabetes J:83526
Icam1tm1Jcgr/Icam1tm1Jcgr
Tg(INS-Il10)#Sar/0

(NOD.Cg-Icam1tm1Jcgr Tg(INS-Il10)#Sar)
decreased susceptibility to autoimmune diabetes J:66103
Icostm1Flv/Icostm1Flv
(involves: 129/Sv * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:87123
Icostm1Flv/Icostm1Flv
(NOD.129S1-Icostm1Flv)
decreased anti-insulin autoantibody level J:131529
decreased autoantibody level J:131529
decreased susceptibility to autoimmune diabetes J:131529
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S4/SvJaeSor)
increased autoantibody level J:93916
Idd3A/J/Idd3A/J
(NOD.A-Idd3A/J)
increased susceptibility to autoimmune diabetes J:120349
Idd3C57BL/6/Idd3C57BL/6
(NOD.B6-Idd3C57BL/6)
decreased susceptibility to autoimmune diabetes J:120349
Idd3CAST/EiJ/Idd3CAST/EiJ
(NOD.CAST-Idd3CAST/EiJ)
increased susceptibility to autoimmune diabetes J:120349
Idd3CZECHI/EiJ/Idd3CZECHI/EiJ
(NOD.CZECH-Idd3CZECHI/EiJ)
decreased susceptibility to autoimmune diabetes J:120349
Idd3SWR/J/Idd3SWR/J
(NOD.SWR-Idd3SWR/J)
increased susceptibility to autoimmune diabetes J:120349
Idd4.3C57L/Idd4.3C57L
(involves: C57L/J * NOD)
increased susceptibility to autoimmune diabetes J:118951
Idd6.1C3H/HeJ/Idd6.1C3H/HeJ
(involves: C3H/HeJ * NOD)
decreased susceptibility to autoimmune diabetes J:115021
Idd6.2C3H/HeJ/Idd6.2C3H/HeJ
(involves: C3H/HeJ * NOD)
decreased susceptibility to autoimmune diabetes J:115021
Idd6.3C3H/HeJ/Idd6.3C3H/HeJ
(involves: C3H/HeJ * NOD)
decreased susceptibility to autoimmune diabetes J:115021
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422)
autoimmune response J:209917
increased anti-double stranded DNA antibody level J:209917
increased anti-nuclear antigen antibody level J:209917
increased susceptibility to systemic lupus erythematosus J:209917
Ifih1Rgsc422/Ifih1Rgsc422
(D2JJcl.B6JJcl-Ifih1Rgsc422)
increased susceptibility to systemic lupus erythematosus J:209917
Ifnb1tm1Tl/Ifnb1tm1Tl
(B10.129P2-Ifnb1tm1Tl)
increased susceptibility to experimental autoimmune encephalomyelitis J:83021
Ifngtm1Ts/Ifngtm1Ts
(NOD.129S7-Ifngtm1Ts)
abnormal susceptibility to autoimmune disorder J:33427
decreased susceptibility to autoimmune diabetes J:95105
Ifngtm1Ts/Ifngtm1Ts
(NOD.Cg-Ifngtm1Ts Prkdcscid)
decreased susceptibility to autoimmune diabetes J:72818
Ifngtm1Ts/Ifngtm1Ts
(NOD.129S7(B6)-Ifngtm1Ts/DvsJ)
decreased susceptibility to autoimmune diabetes J:72818
Ifngtm1Ts/Ifngtm1Ts
(C.129S7-Ifngtm1Ts)
increased susceptibility to experimental autoimmune encephalomyelitis J:34161
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
decreased anti-double stranded DNA antibody level J:39600
decreased anti-nuclear antigen antibody level J:39600
decreased autoantibody level J:39600
decreased susceptibility to autoimmune disorder J:39600
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss)
decreased susceptibility to autoimmune disorder J:119207
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
increased susceptibility to experimental autoimmune encephalomyelitis J:38363
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6)
decreased susceptibility to experimental autoimmune myasthenia gravis J:53577
increased susceptibility to experimental autoimmune uveoretinitis J:99347
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * DBA/1OlaHsd)
increased susceptibility to induced arthritis J:40634
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(NOD.129S1-Ifngr2tm1Pbro)
decreased susceptibility to autoimmune diabetes J:72818
Igh-7tm1Led/Igh-7tm1Led
Lyntm1Ard/Lyntm1Ard

(involves: 129P2/OlaHsd * 129S4/SvJae)
increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
Igh-Jtm1(CB20)Riho/Igh-J+
(involves: C57BL/10 * DBA/1)
increased susceptibility to induced arthritis J:179456
Igh-Jtm1(CB20)Riho/Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1)
increased susceptibility to induced arthritis J:179456
Igh-Jtm1Aigl/Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:111543
Igh-Jtm1Aigl/Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
increased susceptibility to experimental autoimmune encephalomyelitis J:111543
Igh-Jtm1Aigl/Igh-J+
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0

(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Igh-Jtm1Aigl/Igh-J+
Tg(Tcra2D2,Tcrb2D2)1Kuch/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Igh-Jtm1Aigl/Igh-Jtm1Aigl
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0

(involves: 129S1/Sv * 129X1/SvJ * FVB/N * SJL/J)
increased autoantibody level J:149511
increased susceptibility to experimental autoimmune encephalomyelitis J:149511
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
increased anti-double stranded DNA antibody level J:126940
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(involves: 129P2/OlaHsd * BALB/c)
increased anti-double stranded DNA antibody level J:131138
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(B6.129P2-Igh-Jtm2(3H9-VDJ*)Mwg)
increased anti-double stranded DNA antibody level J:142389
Igh-Jtm3(3H9-VDJ*)Mwg/Igh-Jtm3(3H9-VDJ*)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
increased anti-double stranded DNA antibody level J:126940
Ightm1(Ighppc1-5)Cche/Igh+
(B6.Cg-Ightm1(Ighppc1-5)Cche)
increased autoantibody level J:138356
Ightm2.1Hws/Ightm2.1Hws
(involves: BALB/c)
increased anti-nuclear antigen antibody level J:142069
Ighg1em1Wliu/Ighg1em1Wliu
(C57BL/6-Ighg1em1Wliu)
increased anti-double stranded DNA antibody level J:266937
increased anti-nuclear antigen antibody level J:266937
increased autoantibody level J:266937
Ighmtm1Cgn/Ighm+
(NOD.129S2-Ighmtm1Cgn)
increased susceptibility to autoimmune diabetes J:37287
Ighmtm1Cgn/Ighm+
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0

(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt)
increased susceptibility to autoimmune diabetes J:91865
Ighmtm1Cgn/Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn)
decreased susceptibility to autoimmune diabetes J:37287
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
increased susceptibility to induced arthritis J:157619
Ighmtm1Cgn/Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn/DvsJ)
decreased susceptibility to autoimmune diabetes J:80859
Ighmtm1Cgn/Ighmtm1Cgn
Tg(Igh-VB1-8/Igh-6m)1Mjsk/?

(NODCaj.Cg-Ighmtm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ)
increased susceptibility to autoimmune diabetes J:93190
Ighmtm1Cgn/Ighmtm1Cgn
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg

(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ)
decreased susceptibility to autoimmune diabetes J:80859
Ighmtm1Cgn/Ighmtm1Cgn
X/Yaa

(BXSB.129S2(B6)-Ighmtm1Cgn/Dcr)
decreased susceptibility to systemic lupus erythematosus J:206236
Ighmtm1Msn/Ighmtm1Msn
(involves: 129S/SvEv * C57BL/6)
increased anti-double stranded DNA antibody level J:111817
increased autoantibody level J:111817
Igktm1Dhu/Igktm1Dhu
Tg(H2-Ea-HA)HACIIAjca/0
Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0

(C.Cg-Igktm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)
decreased susceptibility to autoimmune disorder J:209872
Igkrstm1Nemz/Igkrstm1Nemz
Tg(BCL2)22Wehi/?

(involves: 129 * C57BL)
increased anti-double stranded DNA antibody level J:132125
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
autoimmune response J:81805
increased anti-double stranded DNA antibody level J:81805
increased anti-histone antibody level J:81805
increased anti-nuclear antigen antibody level J:81805
increased anti-single stranded DNA antibody level J:81805
increased autoantibody level J:81805, J:50626
Ikzf4tm1.1Etms/Ikzf4tm1.1Etms
(Not Specified)
increased susceptibility to experimental autoimmune encephalomyelitis J:295208
Il1atm1Yiw/Il1atm1Yiw
Il1btm1Yiw/Il1btm1Yiw

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:165513
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6)
decreased susceptibility to experimental autoimmune myasthenia gravis J:67001
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
decreased susceptibility to experimental autoimmune uveoretinitis J:115094
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J)
increased susceptibility to induced arthritis J:125570
Il1r1tm1Imx/Il1r1tm1Imx
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx

(involves: 129S7/SvEvBrd * C57BL/6)
decreased susceptibility to experimental autoimmune uveoretinitis J:115094
Il1r1tm1Imx/Il1r1tm1Imx
Vsig4tm1Gne/Vsig4tm1Gne

(B6.Cg-Il1r1tm1Imx Vsig4tm1Gne)
decreased susceptibility to experimental autoimmune encephalomyelitis J:281762
Il1r1tm1Roml/Il1r1tm1Roml
(NOD.Cg-Il1r1tm1Roml)
decreased susceptibility to autoimmune diabetes J:87251
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv)
decreased susceptibility to induced arthritis J:120707
Il1rntm1.1Cga/Il1rntm1.1Cga
Lyz2tm1(cre)Ifo/Lyz2+

(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo)
increased susceptibility to induced arthritis J:162760
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd)
rheumatoid arthritis J:89034
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd * C57BL/6)
rheumatoid arthritis J:89034
Il1rntm1Yiw/Il1rntm1Yiw
(C.129-Il1rntm1Yiw)
rheumatoid arthritis J:143719
Il1rntm1Yiw/Il1rntm1Yiw
Il17atm1Yiw/Il17a+

(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)
decreased susceptibility to induced arthritis J:83408
Il2tm1.1Flv/Il2tm1.1Flv
(NOD/ShiLtJ-Il2tm1.1Flv)
abnormal susceptibility to autoimmune disorder J:150823
Il2tm1Hor/Il2+
(NOD.129P2(B6)-Il2tm1Hor/DvsJ)
increased susceptibility to autoimmune diabetes J:120349
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor)
increased susceptibility to autoimmune hemolytic anemia J:29799
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J)
increased susceptibility to autoimmune disorder J:113547
Il2rbtm1Mak/Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))
increased anti-nuclear antigen antibody level J:25940
increased susceptibility to autoimmune hemolytic anemia J:25940
Il2rbtm1Mak/Il2rbtm1Mak
(B6.129-Il2rbtm1Mak)
increased anti-double stranded DNA antibody level J:113547
increased susceptibility to autoimmune hemolytic anemia J:113547
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
increased anti-double stranded DNA antibody level J:113547
increased susceptibility to autoimmune hemolytic anemia J:113547
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(C.129P2/OlaHsd-Il4/Il13tm3Anjm)
decreased susceptibility to autoimmune disorder J:91403
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(C.129P2/OlaHsd-Il4/Il13tm3Anjm)
decreased susceptibility to autoimmune disorder J:91403
Il4tm1Cgn/Il4tm1Cgn
(NOD.129P2-Il4tm1Cgn)
decreased susceptibility to autoimmune disorder J:95105
increased susceptibility to autoimmune disorder J:95105
Il4tm1Cgn/Il4tm1Cgn
(either: NOD.129-Il4tm1Cgn or (involves: 129 * NOD))
autoimmune response J:85924
Il4tm1Cgn/Il4tm1Cgn
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0

(NOD.Cg-Il4tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
decreased susceptibility to autoimmune diabetes J:85924
Il4tm1Kopf/Il4tm1Kopf
Lyntm1Ard/Lyntm1Ard

(involves: 129P2/OlaHsd * 129S2/SvPas)
increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
Il4tm1Nnt/Il4tm1Nnt
(involves: C57BL/6)
decreased susceptibility to autoimmune disorder J:91403
Il4tm2Nnt/Il4tm2Nnt
(BALB/c-Il4tm2Nnt/J)
decreased susceptibility to autoimmune disorder J:141937
Il5ratm1Ktk/Il5ratm1Ktk
Lyntm1Tya/Lyntm1Tya

(involves: 129P2/OlaHsd * C57BL/6)
increased anti-double stranded DNA antibody level J:91089
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
decreased susceptibility to induced arthritis J:208213
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6)
increased susceptibility to induced arthritis J:142883
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6)
increased anti-double stranded DNA antibody level J:133059
increased anti-nuclear antigen antibody level J:133059
increased anti-single stranded DNA antibody level J:133059
increased autoantibody level J:133059
rheumatoid arthritis J:133059
Il9rtm1Jcrd/Il9rtm1Jcrd
(involves: C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:151907
Il10raNZW/Il10ra+
((NZB x NZW)F1)
increased anti-chromatin antibody level J:102087
Il10ratm1.1Tlg/Il10ratm1.1Tlg
Tg(Cd4-cre)1Cwi/?

(B6.Cg-Tg(Cd4-cre)1Cwi Il10ratm1.1Tlg)
autoimmune response J:189797
Il12atm1Cab/Il12atm1Cab
Il23atm1.1Thak/Il23atm1.1Thak

(B6.Cg-Il12atm1Cab Il23atm1.1Thak)
decreased susceptibility to experimental autoimmune encephalomyelitis J:143970
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J)
increased anti-nuclear antigen antibody level J:106805
Il13tm1.1Anjm/Il13tm1.1Anjm
(C.129P2-Il13tm1.1Anjm)
decreased susceptibility to autoimmune disorder J:141937, J:91403
Il13tm2Anjm/Il13tm2Anjm
(B6.129P2-Il13tm2Anjm)
decreased susceptibility to experimental autoimmune encephalomyelitis J:131969
Il15tm1Imx/Il15tm1Imx
X/Yaa

(BXSB.B6-Il15tm1Imx/Dcr)
increased susceptibility to systemic lupus erythematosus J:179430
Il17atm1Cdon/Il17atm1Cdon
(involves: C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:136279
Il17atm1Yiw/Il17atm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw

(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)
decreased susceptibility to induced arthritis J:83408
Il17atm1Yiw/Il17atm1Yiw
Il17ftm1Yiw/Il17ftm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw

(involves: 129 * BALB/c)
rheumatoid arthritis J:143719
Il17atm1Yiw/Il17atm1Yiw
Tg(CD2-Rorc)#Staka/0

(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to autoimmune disorder J:230700
Il17ctm1.1Cdon/Il17ctm1.1Cdon
(involves: 129S6/SvEvTac)
decreased susceptibility to experimental autoimmune encephalomyelitis J:177650
Il17ftm1Cdon/Il17ftm1Cdon
(involves: C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:136279
Il17ftm1Yiw/Il17ftm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw

(involves: 129 * BALB/c)
rheumatoid arthritis J:143719
Il17rctm1Lex/Il17rctm1Lex
(involves: C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:159874
Il21tm1Lex/Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:123351
increased susceptibility to experimental autoimmune encephalomyelitis J:137377
Il21rtm1Kopf/Il21rtm1Kopf
(B6.129-Il21rtm1Kopf)
increased susceptibility to experimental autoimmune encephalomyelitis J:137377
Il21rtm1Wjl/Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl)
decreased susceptibility to autoimmune diabetes J:139075
Il21rtm1Wjl/Il21rtm1Wjl
X/Yaa

(BXSB.129(Cg)-Il21rtm1Wjl/Dcr)
decreased susceptibility to systemic lupus erythematosus J:144484
Il23atm1.1Thak/Il23atm1.1Thak
(C57BL/6-Il23atm1.1Thak)
decreased susceptibility to experimental autoimmune encephalomyelitis J:143970
Il23atm1Dnax/Il23atm1Dnax
(involves: 129 * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:95542
Il23rtm1Kuch/Il23rtm1Kuch
(C57BL/6-Il23rtm1Kuch)
decreased susceptibility to experimental autoimmune encephalomyelitis J:148248
Il25tm1Dart/Il25tm1Dart
(involves: C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:125296
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua)
increased susceptibility to experimental autoimmune encephalomyelitis J:147706
Il27ratm1Mak/Il27ratm1Mak
(B6.129P2-Il27ratm1Mak)
decreased susceptibility to experimental autoimmune uveoretinitis J:116610
Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to induced arthritis J:151552
Imh1NZB/Imh1NZB
(involves: NZB * NZW)
increased susceptibility to systemic lupus erythematosus J:26266
Imh1NZB/Imh1NZW
(involves: NZB * NZW)
increased susceptibility to systemic lupus erythematosus J:22353
Inpp5dtm1Rav/Inpp5dtm1Rav
Cd79atm1(cre)Reth/Cd79a+
Tg(IghAb36-65)1Wys/0

(involves: 129 * BALB/c * C57BL/6 * FVB/N)
increased autoantibody level J:178833
Ins1tm1Jja/Ins1tm1Jja
(NOD.129S2-Ins1tm1Jja)
decreased susceptibility to autoimmune diabetes J:85309
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)1Ell/0

(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)1Ell)
decreased susceptibility to autoimmune diabetes J:98583
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)3Ell/0

(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)3Ell)
decreased anti-insulin autoantibody level J:98583
decreased susceptibility to autoimmune diabetes J:98583
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Mnt/Ins2tm1Mnt
Tg(Aire-cre)1Mnt/0

(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
increased anti-insulin autoantibody level J:152798
Ins1tm1Jja/Ins1tm1Jja
Tg(Ins2*Y16A)1Ell/0

(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)1Ell)
increased susceptibility to autoimmune diabetes J:98583
Ins1tm1Jja/Ins1tm1Jja
Tg(Ins2*Y16A)3Ell/0

(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)3Ell)
autoimmune response J:98583
Ins2C95S/Ins2+
(C3HeB/FeJ-Ins2C95S)
increased susceptibility to autoimmune diabetes J:122098
Ins2C95S/Ins2C95S
(C3HeB/FeJ-Ins2C95S)
increased susceptibility to autoimmune diabetes J:122098
Ins2tm1Jja/Ins2tm1Jja
(NOD.129S2-Ins2tm1Jja)
increased anti-insulin autoantibody level J:85309
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)3Ell/0

(NOD.Cg-Ins2tm1Jja Tg(Ins2*Y16A)3Ell)
autoimmune response J:98583
increased anti-insulin autoantibody level J:98583
Irak1tm1Jth/Y
(B6.Cg-Irak1tm1Jth)
decreased susceptibility to experimental autoimmune encephalomyelitis J:82302
Irak1tm1Jth/Irak1tm1Jth
(B6.Cg-Irak1tm1Jth)
decreased susceptibility to experimental autoimmune encephalomyelitis J:82302
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv)
increased anti-insulin autoantibody level J:229884
increased susceptibility to autoimmune diabetes J:229884
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6)
decreased susceptibility to induced arthritis J:43086
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129)
decreased susceptibility to experimental autoimmune encephalomyelitis J:84367
Irs1tm1Mfw/Irs1tm1Mfw
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
increased susceptibility to autoimmune diabetes J:137845
Irs1tm2Tka/Irs1tm2Tka
Irs2tm2Tka/Irs2tm2Tka
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
increased susceptibility to autoimmune diabetes J:137846
Itgavtm2Hyn/Itgavtm2.1Hyn
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB)
increased autoantibody level J:125508
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Tek-cre)1Ywa/?

(involves: 129S2/SvPas * C57BL/6 * FVB * SJL)
increased autoantibody level J:125508
Itgaxtm1Bll/Itgaxtm1Bll
(B6.129S7-Itgaxtm1Bll)
decreased susceptibility to experimental autoimmune encephalomyelitis J:122187
Itgb2tm1Bay/Itgb2tm1Bay
Psrs1PL/J/Psrs1PL/J

(B6.Cg-(D10Mit126-D10Mit38) Itgb2tm1Bay)
rheumatoid arthritis J:134251
Itgb2tm1Bay/Itgb2tm1Bay
Psrs1PL/J/Psrs1PL/J

(B6.Cg-(D10Mit75-D10Mit271) Itgb2tm1Bay)
rheumatoid arthritis J:134251
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda)
increased anti-nuclear antigen antibody level J:199153
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0

(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
increased anti-histone antibody level J:155575
increased susceptibility to systemic lupus erythematosus J:155575
KitW-sh/KitW-sh
Lyntm1Ard/Lyntm1Ard

(involves: 101 * 129P2/OlaHsd * C3H/HeH)
increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
KitW/KitW-v
((WB KitW x B6.Cg-KitW-v)F1)
decreased susceptibility to induced arthritis J:178942
Ksr1tm1Shaw/Ksr1tm1Shaw
(Not Specified)
decreased susceptibility to induced arthritis J:140520
Lag3tm1Daav/Lag3+
Tg(Foxp3-EGFP/cre)1cJbs/0

(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)
decreased susceptibility to autoimmune diabetes J:260063
Lag3tm1Daav/Lag3tm1Daav
Tg(Foxp3-EGFP/cre)1cJbs/0

(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)
decreased susceptibility to autoimmune diabetes J:260063
Laq1MRL/Laq1MRL
(involves: C57BL/6 * MRL)
increased susceptibility to autoimmune disorder J:45708
Lat2tm1Mal/Lat2tm1Mal
(B6.129S2-Lat2tm1Mal)
increased anti-nuclear antigen antibody level J:126321
Lat2tm1Mal/Lat2tm1Mal
Lime1tm1.1Mal/Lime1tm1.1Mal

(involves: 129 * C57BL/6)
increased anti-nuclear antigen antibody level J:126321
Lat2tm1Wz/Lat2tm1Wz
(B6.Cg-Lat2tm1Wz)
increased anti-double stranded DNA antibody level J:116157
increased autoantibody level J:116157
Lat2tm2Wz/Lat2tm2Wz
Tg(Lck-cre)548Jxm/0

(involves: C57BL/6)
increased anti-double stranded DNA antibody level J:116157
Lattm1.1Lov/Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased anti-double stranded DNA antibody level J:116157
increased anti-nuclear antigen antibody level J:77099
increased autoantibody level J:77099
Lattm1.1Lov/Lattm1.1Lov
Lat2tm1Wz/Lat2tm1Wz

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased anti-double stranded DNA antibody level J:116157
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
increased anti-chromatin antibody level J:125722
increased anti-erythrocyte antigen antibody level J:125722
increased anti-nuclear antigen antibody level J:125722
increased susceptibility to autoimmune hemolytic anemia J:125722
Lbric-J/Lbr+
((NZW/LacJ x C57BL/6J-Lbric-J/J)F1)
increased anti-chromatin antibody level J:234168
increased anti-nuclear antigen antibody level J:234168
increased autoantibody level J:234168
increased susceptibility to systemic lupus erythematosus J:234168
Lbw2NZB/BlScr/Lbw2NZB/BlScr
(involves: NZB * NZW)
increased anti-chromatin antibody level J:98150
increased autoantibody level J:98150
Lbw2NZB/BlScr/Lbw2NZW/LacScr
(involves: NZB * NZW)
increased anti-chromatin antibody level J:98150
increased autoantibody level J:98150
Lbw2NZW/LacScr/Lbw2NZW/LacScr
(involves: NZB * NZW)
decreased autoantibody level J:98150
Lbw5NZW/LacScr/Lbw5NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr)
increased susceptibility to systemic lupus erythematosus J:20991
Lbw5NZW/LacScr/Lbw5NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr)
increased susceptibility to systemic lupus erythematosus J:20991
Lbw6NZW/LacScr/Lbw6NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr)
increased susceptibility to systemic lupus erythematosus J:20991
Lbw7NZB/BlScr/Lbw7NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr)
increased susceptibility to systemic lupus erythematosus J:20991
Lbw7NZB/BlScr/Lbw7NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr)
increased susceptibility to systemic lupus erythematosus J:20991
Lbw8NZB/BlScr/Lbw8NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr)
increased susceptibility to autoimmune disorder J:20991
Lbw8NZB/BlScr/Lbw8NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr)
increased susceptibility to autoimmune disorder J:20991
Lcp2twm/Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu)
autoimmune response J:104190
Lctlp1FVB/NJ/Lctlp1FVB/NJ
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:122919
Lctlp2FVB/NJ/Lctlp2FVB/NJ
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:122919
Leprdb/Leprdb
(involves: C57BLKS/J)
increased susceptibility to autoimmune diabetes J:7005
Lgals1tm1Rob/Lgals1tm1Rob
(involves: 129S/SvEv)
increased susceptibility to experimental autoimmune encephalomyelitis J:123416
Lgals9tm1Glp/Lgals9tm1Glp
(B6.129S6-Lgals9tm1Glp)
increased susceptibility to induced arthritis J:132889
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
increased anti-chromatin antibody level J:157574
increased anti-double stranded DNA antibody level J:157574
ll/ll
X/Yaa

(BXSB/MpJScr-ll)
decreased anti-nuclear antigen antibody level J:10973
decreased susceptibility to autoimmune disorder J:10973
Lmb1C57BL/6Scr/Lmb1C57BL/6Scr
(involves: C57BL/6-Faslpr * MRL-Faslpr)
increased anti-double stranded DNA antibody level J:45708
Lmb1C57BL/6Scr/Lmb1MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr)
increased anti-double stranded DNA antibody level J:45708
Lmb2C57BL/6Scr/Lmb2MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr)
increased anti-double stranded DNA antibody level J:45708
Lmb2MRL/MpScr/Lmb2MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr)
increased anti-double stranded DNA antibody level J:45708
Lrch1em1Hwa/Lrch1em1Hwa
(Not Specified)
increased susceptibility to experimental autoimmune encephalomyelitis J:238772
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129/Sv * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
decreased susceptibility to induced arthritis J:115034
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129/Sv * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
decreased susceptibility to induced arthritis J:115034
Lta/Tnftm1Jods/Lta/Tnftm1Jods
(C57BL/6-Lta/Tnftm1Jods)
decreased susceptibility to experimental autoimmune encephalomyelitis J:47428
Lta/Tnftm1Jods/Lta/Tnftm1Jods
(C57BL/6-Lta/Tnftm1Jods)
decreased susceptibility to experimental autoimmune encephalomyelitis J:47428
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(involves: 129S4/SvJaeSor * C57BL/6)
decreased susceptibility to autoimmune disorder J:108446
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(involves: 129S4/SvJaeSor)
decreased susceptibility to induced arthritis J:131779
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(either: (involves: 129S4/SvJaeSor * BALB/c ) or (involves: 129S4/SvJaeSor * C57BL/6))
decreased susceptibility to induced arthritis J:163271
Ltb4r2tm1Bodd/Ltb4r2tm1Bodd
(involves: 129S4/SvJaeSor * C57BL/6)
decreased susceptibility to induced arthritis J:163271
Ltc4stm1Blam/Ltc4stm1Blam
(C.129S7-Ltc4stm1Blam)
autoimmune response J:182213
Lxw1BXSB/Scr/?
(involves: BXSB/Scr * NZW/LacScr)
increased anti-chromatin antibody level J:86924
Lxw3NZW/LacScr/?
(involves: BXSB/Scr * NZW/LacScr)
increased anti-chromatin antibody level J:86924
Lynmld4/Lynmld4
(involves: C57BL/6)
increased anti-double stranded DNA antibody level J:144799
Lyntm1.1Calo/Lyntm1.1Calo
Tg(Itgax-cre)1-1Reiz/0

(involves: 129P2/OlaHsd * C57BL/6 * CBA)
increased autoantibody level J:200745
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd)
increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
Lyntm1Ard/Lyntm1Ard
(B6.129P2-Lyntm1Ard)
increased anti-double stranded DNA antibody level J:144799
increased anti-nuclear antigen antibody level J:144799
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJae)
increased anti-double stranded DNA antibody level J:42037
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor)
increased anti-double stranded DNA antibody level J:146161
increased autoantibody level J:200745
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
increased anti-double stranded DNA antibody level J:71174
increased susceptibility to systemic lupus erythematosus J:71174
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
increased anti-double stranded DNA antibody level J:29751
Lynweeb/Lynweeb
(C57BL/6-Lynweeb)
increased anti-double stranded DNA antibody level J:146161
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
Nrrostm1Wouy/Nrrostm1Wouy

(involves: 129P2/OlaHsd)
increased susceptibility to experimental autoimmune encephalomyelitis J:209569
Map4k1tm1Tht/Map4k1tm1Tht
(B6.129S7-Map4k1tm1Tht)
increased susceptibility to experimental autoimmune encephalomyelitis J:116613
Map4k3Gt(RRO270)Byg/Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd)
decreased susceptibility to experimental autoimmune encephalomyelitis J:177642
Mapk3tm1Gela/Mapk3tm1Gela
(either: 129(Cg)-Mapk3tm1Gela or B6.129-Mapk3tm1Gela)
increased susceptibility to experimental autoimmune encephalomyelitis J:107504
Mapk11tm1Jda/Mapk11tm1Jda
Mapk14tm1Jda/Mapk14tm1Jda

(involves: 129 * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:165966
decreased susceptibility to induced arthritis J:165966
Mbpshi/Mbpshi
(involves: BALB/c * C3HeB/Fe * SWV)
increased susceptibility to experimental autoimmune encephalomyelitis J:48412
Mcph1Tg(HLA-A2.1)1Enge/Mcph1+
(NOD.B6-Mcph1Tg(HLA-A2.1)1Enge)
increased susceptibility to autoimmune diabetes J:109851
Mcph1Tg(HLA-A2.1)1Enge/Mcph1Tg(HLA-A2.1)1Enge
(NOD.B6-Mcph1Tg(HLA-A2.1)1Enge)
increased susceptibility to autoimmune diabetes J:109851
Mertktm1Gkm/Mertktm1Gkm
(NOD.129P2-Mertktm1Gkm)
decreased susceptibility to autoimmune diabetes J:147153
Mertktm1Gkm/Mertktm1Gkm
(B6.129P2-Mertktm1Gkm)
decreased autoantibody level J:136377
Mex3btm1.1Mbld/Mex3btm1.1Mbld
Plekha5Tg(AMH-cre)1Flor/Plekha5+

(involves: C57BL/6 * SJL)
increased anti-sperm antibody level J:213588
Mfge8tm1Osa/Mfge8tm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased anti-double stranded DNA antibody level J:225063
Mfge8tm1Osa/Mfge8tm1Osa
Timd4tm1Osa/Timd4tm1Osa

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
increased anti-double stranded DNA antibody level J:187181
increased anti-nuclear antigen antibody level J:187181
Mir125atm1Smoc/Mir125atm1Smoc
(involves: C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:224880
Mir140tm1.1Asah/Mir140tm1.1Asah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
increased susceptibility to induced arthritis J:160358
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Tg(Cr2-cre)3Cgn/0

(involves: C57BL/6)
increased anti-double stranded DNA antibody level J:266124
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
increased anti-double stranded DNA antibody level J:173671
Mir155tm1.1Rsky/Mir155tm1.1Rsky
(B6.Cg-Mir155tm1Rsky/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:226678
Mir210tm1.1Wtsi/Mir210tm1.1Wtsi
(involves: C57BL/6J * C57BL/6N)
increased anti-chromatin antibody level J:205868
increased anti-double stranded DNA antibody level J:205868
increased anti-nuclear antigen antibody level J:205868
Mirc33tm1.1Cwh/Mirc33tm1.1Cwh
(involves: 129X1/SvJ)
decreased susceptibility to experimental autoimmune encephalomyelitis J:189763
Mmdtm1Beij/Mmdtm1Beij
(Not Specified)
decreased susceptibility to induced arthritis J:304637
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
increased susceptibility to experimental autoimmune encephalomyelitis J:94099
Mmp9tm1Arnd/Mmp9tm1Arnd
(involves: 129P2/OlaHsd)
decreased susceptibility to experimental autoimmune encephalomyelitis J:58833
Mmp9tm1Tvu/Mmp9tm1Tvu
(C3N.129S6-Mmp9tm1Tvu)
decreased susceptibility to induced arthritis J:150311
Mogtm1(cre)Gkl/Mogtm1(cre)Gkl
Tg(Tcra2D2,Tcrb2D2)1Kuch/0

(C57BL/6-Mogtm1(cre)Gkl Tg(Tcra2D2,Tcrb2D2)1Kuch)
increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Mogtm1Dpd/Mogtm1Dpd
(B6.129S2-Mogtm1Dpd)
decreased susceptibility to experimental autoimmune encephalomyelitis J:85155
Mogtm1Dpd/Mogtm1Dpd
Rag2tm1Cgn/Rag2tm1Cgn
Tg(Tcra2D2,Tcrb2D2)1Kuch/0

(involves: 129S2/SvPas * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Mogtm1Dpd/Mogtm1Dpd
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0

(SJL.Cg-Mogtm1Dpd Tg(H2-Kb-Tcra,-Tcrb)1640Kurs)
decreased susceptibility to experimental autoimmune encephalomyelitis J:149511
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0

(involves: 129S2/SvPas * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Mogtm1Reid/Mogtm1Reid
(B6.129S1/Sv-Mogtm1Reid)
increased susceptibility to experimental autoimmune encephalomyelitis J:86663
Mogtm1Reid/Mogtm1Reid
(129/Sv-Mogtm1Reid)
increased susceptibility to experimental autoimmune encephalomyelitis J:86663
Mpgtm1Lds/Mpgtm1Lds
(involves: 129P2/OlaHsd * C57BL/6)
autoimmune response J:118148
decreased susceptibility to autoimmune diabetes J:118148
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J)
increased susceptibility to experimental autoimmune encephalomyelitis J:102965
Mpztm1Msch/Mpz+
(B6.129S7-Mpztm1Msch)
autoimmune response J:59319
Mr1tm1Gfn/Mr1tm1Gfn
(B6.129P2-Mr1tm1Gfn)
increased susceptibility to experimental autoimmune encephalomyelitis J:112657
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri

(involves: 129S7/SvEvBrd)
increased susceptibility to experimental autoimmune encephalomyelitis J:103102
mt-Nd2m1
(ALR/Lt)
decreased susceptibility to autoimmune diabetes J:117602, J:97969
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
increased anti-double stranded DNA antibody level J:137101
increased autoantibody level J:137101
increased susceptibility to systemic lupus erythematosus J:137101
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to systemic lupus erythematosus J:212144
Mtv7BALB/c/Mtv7BALB/c
(involves: B10.Q * BALB/c * DBA/2)
increased susceptibility to induced arthritis J:27701
Mtv7BALB/c/Mtv7DBA/2
(involves: B10.Q * BALB/c * DBA/2)
decreased susceptibility to induced arthritis J:27701
Mtv7DBA/2/Mtv7DBA/2
(C.D2-Mtv7DBA/2)
decreased susceptibility to induced arthritis J:27701
Muc19sld/Muc19sld
(NFS/N-Muc19sld)
increased susceptibility to autoimmune disorder J:216958, J:20364
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
decreased susceptibility to experimental autoimmune encephalomyelitis J:105435
Myd88tm1Aki/Myd88tm1Aki
(C.129P2-Myd88tm1Aki)
decreased susceptibility to induced arthritis J:178054
Myd88tm1Aki/Myd88tm1Aki
Tanktm1Aki/Tanktm1Aki

(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
increased anti-double stranded DNA antibody level J:151757
Nba4NZB/Nba4NZB
(involves: NZB * SWR)
increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96263
increased anti-single stranded DNA antibody level J:96060
Nba4NZB/Nba4SWR
(involves: NZB * SWR)
increased anti-histone antibody level J:96263
Nba10NZB/?
(involves: C57BL/6 * NZB * SB/Le)
increased anti-chromatin antibody level J:95829
increased anti-double stranded DNA antibody level J:95829
Nba10NZB/Nba10NZB
Tg(Tnfsf13b)1Fma/0

(involves: C57BL/6 * DBA/2J * NZB)
increased anti-chromatin antibody level J:134128
increased anti-double stranded DNA antibody level J:134128
increased susceptibility to systemic lupus erythematosus J:134128
Nba10NZB/Nba10NZB
Tlr7tm1Aki/Y
X/Yaa

(B6.Cg-Nba10NZB Tlr7tm1Aki Yaa)
increased anti-chromatin antibody level J:137656
Nba10NZB/Nba10NZB
X/Yaa

(C57BL/6-Nba2 Yaa)
increased anti-chromatin antibody level J:137656
increased anti-nuclear antigen antibody level J:95829
increased autoantibody level J:137656
increased susceptibility to autoimmune disorder J:95829
Nba12NZB/Nba12NZB
(involves: NZB * SWR)
increased anti-double stranded DNA antibody level J:96263
Nba12NZB/Nba12SWR
(involves: NZB * SWR)
increased anti-double stranded DNA antibody level J:96263
Nbwa1NZB/?
(involves: BALB/c * NZB * NZW)
increased anti-chromatin antibody level J:88464
increased anti-double stranded DNA antibody level J:88464
increased anti-single stranded DNA antibody level J:88464
increased susceptibility to systemic lupus erythematosus J:88464
Nbwa2NZB/?
(involves: BALB/c * NZB * NZW)
increased susceptibility to systemic lupus erythematosus J:88464
Nbwa2NZW/?
(involves: BALB/c * NZB * NZW)
increased anti-double stranded DNA antibody level J:88464
increased susceptibility to systemic lupus erythematosus J:88464
Ncf2tm1b(EUCOMM)Wtsi/Ncf2+
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
increased anti-double stranded DNA antibody level J:260777
increased susceptibility to systemic lupus erythematosus J:260777
Ncf2tm1b(EUCOMM)Wtsi/Ncf2tm1b(EUCOMM)Wtsi
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
increased anti-double stranded DNA antibody level J:260777
increased susceptibility to systemic lupus erythematosus J:260777
Ndst2tm1Rls/Ndst2tm1Rls
(B6.Cg-Ndst2tm1Rls)
decreased susceptibility to induced arthritis J:142880
Nek7M1Btlr/Nek7M1Btlr
(C57BL/6J-Nek7M1Btlr)
decreased susceptibility to experimental autoimmune encephalomyelitis J:226677
Nfatc1tm1Rao/Nfatc1tm1Rao
Cd79atm1(cre)Reth/Cd79a+

(involves: BALB/c)
decreased susceptibility to experimental autoimmune encephalomyelitis J:177319
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR)
increased anti-double stranded DNA antibody level J:104016
increased anti-nuclear antigen antibody level J:104016
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6)
increased susceptibility to experimental autoimmune uveoretinitis J:150597
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(B6.129X1-Nfe2l2tm1Ywk)
increased anti-double stranded DNA antibody level J:165602
Nfil3tm1.1Kubo/Nfil3tm1.1Kubo
(B6.Cg-Nfil3tm1.1Kubo)
increased susceptibility to experimental autoimmune encephalomyelitis J:172134
Nfkb1tm1Bal/Nfkb1tm1Bal
(B6;129P-Nfkb1tm1Bal/J)
decreased susceptibility to autoimmune diabetes J:118907
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c)
autoimmune response J:154812
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6)
autoimmune response J:163686
increased anti-insulin autoantibody level J:163686
increased anti-nuclear antigen antibody level J:163686
Nfkbibtm1Bal/Nfkbibtm1Bal
(B6.129S1-Nfkbibtm1Bal)
decreased susceptibility to induced arthritis J:163302
Ngfrtm1Jae/Ngfrtm1Jae
(B6.129S4-Ngfrtm1Jae)
increased susceptibility to experimental autoimmune encephalomyelitis J:112769
Ninj1tm1Gto/Ninj1+
(B6.129P2-Ninj1tm1Gto)
decreased susceptibility to experimental autoimmune encephalomyelitis J:209516
Ninj1tm1Gto/Ninj1tm1Gto
(B6.129P2-Ninj1tm1Gto)
decreased susceptibility to experimental autoimmune encephalomyelitis J:209516
Nlrp3M6Btlr/Nlrp3M6Btlr
(C57BL/6J-Nlrp3M6Btlr)
decreased susceptibility to experimental autoimmune encephalomyelitis J:226677
Nlrp3tm1Wstr/Nlrp3+
(involves: C57BL/6)
increased anti-double stranded DNA antibody level J:150053
Nlrp3tm2Hhf/Nlrp3tm2Hhf
Vsig4tm1Gne/Vsig4tm1Gne

(B6.Cg-Nlrp3tm2Hhf Vsig4tm1Gne)
decreased susceptibility to experimental autoimmune encephalomyelitis J:281762
Nlrp10tm1Seis/Nlrp10tm1Seis
(B6.Cg-Nlrp10tm1Seis)
decreased susceptibility to experimental autoimmune encephalomyelitis J:183989
Nod2tm1Flv/Nod2tm1Flv
(C.129S1-Nod2tm1Flv)
decreased susceptibility to induced arthritis J:178054
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * PL/J)
increased susceptibility to experimental autoimmune encephalomyelitis J:46192
Nr3c1tm2.1Gsc/Nr3c1+
(B6.129P2-Nr3c1tm2.1Gsc)
increased susceptibility to experimental autoimmune encephalomyelitis J:137157
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Lck-cre)I57Jxm/0

(B6.Cg-Nr3c1tm2Gsc Tg(Lck-cre)I57Jxm)
increased susceptibility to experimental autoimmune encephalomyelitis J:137157
Nrrostm1Lex/Nrrostm1Lex
(B6.129S5-Nrrostm1Lex)
increased susceptibility to experimental autoimmune encephalomyelitis J:209569
Nudt7em1Ejj/Nudt7em1Ejj
(involves: C57BL/6N)
increased susceptibility to induced arthritis J:266261
Nwa2NZW/LacJ/Nwa2NZW/LacJ
(involves: BALB/cJ * NZW/LacJ)
increased anti-histone antibody level J:35434
increased anti-single stranded DNA antibody level J:35434
Otub1tm1c(EUCOMM)Hmgu/Otub1tm1c(EUCOMM)Hmgu
Cd19tm1(cre)Cgn/Cd19+

(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
increased anti-double stranded DNA antibody level J:280549
increased anti-nuclear antigen antibody level J:280549
increased susceptibility to autoimmune disorder J:280549
increased susceptibility to systemic lupus erythematosus J:280549
Paam1MRL/MpJ/Paam1MRL/MpJ
(involves: C3H/HeJ * MRL/MpJ)
increased susceptibility to autoimmune disorder J:76107
Paam2MRL/MpJ/Paam2MRL/MpJ
(involves: C3H/HeJ * MRL/MpJ)
increased susceptibility to autoimmune disorder J:76107
Padi2tm1Lex/Padi2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
autoimmune response J:190651
Panx3tm1c(KOMP)Wtsi/Panx3tm1c(KOMP)Wtsi
Tg(Col2a1-cre)1Star/0

(involves: C3H * C57BL/6 * C57BL/6J * C57BL/6N)
decreased susceptibility to induced arthritis J:233542
Panx3tm1d(KOMP)Wtsi/Panx3tm1d(KOMP)Wtsi
(involves: BALB/cJ * C3H * C57BL/6 * C57BL/6N)
decreased susceptibility to induced arthritis J:233542
Pbat1BXSB/Slc/Pbat1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc)
increased autoantibody level J:49899
Pbat1BXSB/Slc/Pbat1NZW/Slc
(involves: BXSB/Slc * NZW/Slc)
increased autoantibody level J:49899
Pbat2BXSB/Slc/Pbat2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc)
increased autoantibody level J:49899
Pbat2BXSB/Slc/Pbat2NZW/Slc
(involves: BXSB/Slc * NZW/Slc)
increased autoantibody level J:49899
Pdcd1tm1.1Shr/Pdcd1tm1.1Shr
Tg(TcraTcrb)1100Mjb/0

(involves: C57BL/6)
increased susceptibility to autoimmune diabetes J:153040
Pdcd1tm1Hon/Pdcd1tm1Hon
(C.129S2(B6)-Pdcd1tm1Hon)
increased autoantibody level J:66979
Pdcd1tm1Hon/Pdcd1tm1Hon
Tg(Tcra2D2,Tcrb2D2)1Kuch/0

(involves: 129S2/SvPas)
decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
Pdcd1tm1Hon/Pdcd1tm1Hon
Vsirtm1Lex/Vsirtm1Lex
Tg(Tcra2D2,Tcrb2D2)1Kuch/0

(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:222944
Pdcd1tm1Llc/Pdcd1tm1Llc
(involves: 129S5/SvEvBrd)
increased susceptibility to experimental autoimmune encephalomyelitis J:126829
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac)
increased susceptibility to autoimmune diabetes J:123785
Pdcd4tm1Yhcn/Pdcd4tm1Yhcn
(B6.129S6-Pdcd4tm1Yhcn)
decreased susceptibility to autoimmune diabetes J:120583
decreased susceptibility to experimental autoimmune encephalomyelitis J:120583
Pecam1tm1Mak/Pecam1+
(D1.129P2-Pecam1tm1Mak)
increased susceptibility to induced arthritis J:106275
Pecam1tm1Mak/Pecam1tm1Mak
(D1.129P2-Pecam1tm1Mak)
increased susceptibility to induced arthritis J:106275
Pgam1tm1.1Hiko/Pgam1tm1.1Hiko
Tg(Cd4-cre)1Cwi/0

(involves: C57BL/6 * DBA/2)
decreased susceptibility to experimental autoimmune encephalomyelitis J:293746
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(involves: 129 * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:181221
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra)
increased anti-double stranded DNA antibody level J:203443
increased anti-single stranded DNA antibody level J:203443
Pgia1BALB/cCrl/Pgia1DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl)
increased autoantibody level J:66460
increased susceptibility to autoimmune disorder J:66460
Pgia2BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
increased autoantibody level J:66460
Pgia3DBA/2Crl/?
(involves: BALB/cCrl * DBA/2Crl)
increased autoantibody level J:66460
Pgia4BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
increased autoantibody level J:66460
Pgia6BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
increased autoantibody level J:66460
Pgia7BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
increased autoantibody level J:66460
Pgia8DBA/2/Pgia8DBA/2
(C.D2-(D15Mit12-D15Mit267))
decreased susceptibility to induced arthritis J:137478
Pgia8DBA/2/Pgia8DBA/2
(involves: BALB/c * DBA/2)
decreased susceptibility to induced arthritis J:137478
Pgia9DBA/2/Pgia9DBA/2
(C.D2-(D15Mit267-D15Mit41))
decreased susceptibility to induced arthritis J:137478
Pgia9DBA/2/Pgia9DBA/2
(involves: BALB/c * DBA/2)
decreased susceptibility to induced arthritis J:137478
Pgia10BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
increased autoantibody level J:66460
Pgia11BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl)
increased autoantibody level J:66460
Pgia13C3H/HeJCr/Pgia13C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
increased susceptibility to induced arthritis J:65424
Pgia14C3H/HeJCr/Pgia14C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
increased susceptibility to induced arthritis J:65424
Pgia15C3H/HeJCr/Pgia15C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
increased susceptibility to induced arthritis J:65424
Pgia16C3H/HeJCr/Pgia16C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6)
increased susceptibility to autoimmune disorder J:65424
Pgia39DBA/2Crl/Pgia39DBA/2Crl
Pgia6DBA/2Crl/Pgia6DBA/2Crl

(involves: BALB/cCrl * DBA/2Crl)
increased susceptibility to induced arthritis J:84150
Pgia39DBA/2Crl/Pgia39DBA/2Crl
Pgia26BALB/cCrl/Pgia26BALB/cCrl

(involves: BALB/cCrl * DBA/2Crl)
increased susceptibility to induced arthritis J:84150
Pgis1DBA/2/Pgis1DBA/2
(involves: BALB/c * DBA/2)
increased susceptibility to induced arthritis J:107496
Pgis1DBA/2/Pgis1DBA/2
Pgis2BALB/c/Pgis2BALB/c

(involves: BALB/c * DBA/2)
increased susceptibility to induced arthritis J:107496
Pgis1DBA/2/Pgis1DBA/2
Pgis2BALB/c/Pgis2DBA/2

(involves: BALB/c * DBA/2)
increased susceptibility to induced arthritis J:107496
Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2)
increased susceptibility to induced arthritis J:107496
Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2)
increased susceptibility to induced arthritis J:107496
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(C.129S-Pglyrp1tm1Rdz)
increased susceptibility to induced arthritis J:178054
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz

(C.129S-Pglyrp1tm1Rdz Pglyrp2tm1Rdz)
decreased susceptibility to induced arthritis J:178054
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(C.129S-Pglyrp2tm1Rdz)
decreased susceptibility to induced arthritis J:178054
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
increased anti-double stranded DNA antibody level J:169710
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(B6.129S4-Pik3cdtm1Tnr)
decreased susceptibility to induced arthritis J:134324
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Pik3cgtm1Pngr/Pik3cgtm1Pngr

(B6.129-Pik3cdtm1Tnr Pik3cgtm1Pngr)
decreased susceptibility to induced arthritis J:134324
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129P2-Pik3cgtm1Pngr)
decreased susceptibility to induced arthritis J:134324
Pkn1tm1Kik/Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik)
increased anti-double stranded DNA antibody level J:193187
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(B6.129P2-Pla2g4atm1Tksh)
decreased susceptibility to experimental autoimmune encephalomyelitis J:107430
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg)
decreased susceptibility to induced arthritis J:75303
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0

(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))
increased anti-double stranded DNA antibody level J:157757
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd)
decreased susceptibility to induced arthritis J:157619
Plcl2tm1Tta/Plcl2tm1Tta
(involves: 129P2/OlaHsd)
increased anti-nuclear antigen antibody level J:85960
Pld4thss/Pld4thss
(BALB/cJ-Pld4thss/GrsrJ)
increased anti-nuclear antigen antibody level J:278304
plt/plt
(either: B6.DDD-plt or C.DDD-plt)
increased susceptibility to autoimmune disorder J:110910
Polbtm1.1Jbsw/Polb+
(involves: 129/Sv * C57BL/6)
increased anti-nuclear antigen antibody level J:206872
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
increased anti-nuclear antigen antibody level J:206872
increased susceptibility to systemic lupus erythematosus J:206872
Ppargtm1.1Gonz/Ppargtm1.1Gonz
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
increased anti-double stranded DNA antibody level J:168799
increased anti-nuclear antigen antibody level J:168799
increased anti-single stranded DNA antibody level J:168799
increased autoantibody level J:168799
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA * ICR)
increased susceptibility to induced arthritis J:58222
Ppargtm2Rev/Ppargtm2Rev
Tg(Cd4-cre)1Cwi/?

(involves: 129S4/SvJae * C57BL/6 * DBA/2)
increased susceptibility to experimental autoimmune encephalomyelitis J:153358
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Itgax-cre)1-1Reiz/0

(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
increased anti-double stranded DNA antibody level J:178876
increased anti-nuclear antigen antibody level J:178876
increased autoantibody level J:178876
Prf1tm1Clrk/Prf1tm1Clrk
(involves: 129S7/SvEvBrd * BALB/c * NOD)
decreased susceptibility to autoimmune diabetes J:64051
Prf1tm1Clrk/Prf1tm1Clrk
Tg(INS-Il10)#Sar/0

(involves: 129S7/SvEvBrd * BALB/c * NOD)
decreased susceptibility to autoimmune diabetes J:64051
Prf1tm1Sdz/Prf1+
(NOD.B6-Prf1tm1Sdz)
decreased susceptibility to autoimmune diabetes J:43468
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz)
decreased susceptibility to autoimmune diabetes J:43468
Prf1tm1Sdz/Prf1tm1Sdz
X/Yaa

(BXSB.B6-Prf1tm1Sdz/Dcr)
autoimmune response J:179430
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
increased anti-chromatin antibody level J:76135
Prkcdtm1Qxu/Prkcdtm1Qxu
(involves: 129P2/OlaHsd * C57BL/6)
increased anti-nuclear antigen antibody level J:76134
Prkcdtm1Qxu/Prkcdtm1Qxu
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0

(involves: 129P2/OlaHsd * C57BL/6)
autoimmune response J:76134
Prkcitm1Rfar/Prkci+
Tg(Ckmm-cre)5Khn/?

(involves: 129P2/OlaHsd * C57BL/6 * FVB)
increased susceptibility to autoimmune diabetes J:123964
Prkcqtm1Litt/Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
decreased susceptibility to experimental autoimmune encephalomyelitis J:129421
Prkdcscid/Prkdcscid
Tg(Ins2-Fasl)24Ach/0

(NOD.Cg-Prkdcscid Tg(Ins2-Fasl)24Ach)
decreased susceptibility to autoimmune diabetes J:81416
increased susceptibility to autoimmune diabetes J:81416
Prkdcscid/Prkdcscid
Tg(INS-Il10)#Sar/0

(NOD.Cg-Prkdcscid Tg(INS-Il10)#Sar)
increased susceptibility to autoimmune diabetes J:66103
Prkdcscid/Prkdcscid
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0

(NOD.Cg-Prkdcscid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
increased susceptibility to autoimmune diabetes J:93553
Psen1tm1Bdes/Psen1+
Psen2tm1Bdes/Psen2tm1Bdes

(involves: 129P2/OlaHsd)
autoimmune response J:91235
increased anti-single stranded DNA antibody level J:91235
increased susceptibility to autoimmune disorder J:91235
Pstpip2Lupo/Pstpip2Lupo
(either: (involves: C3HeB/FeJ) or (involves: C3HeB/FeJ * C57BL/6J))
increased autoantibody level J:125785
Pstpip2m1Bcs/Pstpip2m1Bcs
(involves: C57BL/6)
autoimmune response J:196534
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
decreased susceptibility to induced arthritis J:78964
rheumatoid arthritis J:78964
Ptgs1tm1Unc/Ptgs1tm1Unc
(B6.129P2-Ptgs1tm1Unc)
decreased susceptibility to induced arthritis J:110716
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
decreased susceptibility to induced arthritis J:110716
Ptpn6m1Btlr/Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd)
increased anti-chromatin antibody level J:142845
Ptpn6me-v/Ptpn6me-v
(C57BL/6J-Ptpn6me-v)
rheumatoid arthritis J:20845
Ptpn6me/Ptpn6me
(C57BL/6J-Ptpn6me/J)
autoimmune response J:5579
Ptpn6me/Ptpn6me
(involves: C3H/HeN * C57BL/6J * NFS)
increased autoantibody level J:30994
Ptpn12tm1Vei/Ptpn12tm1Vei
Tg(Lck-cre)1Cwi/0

(B6.Cg-Ptpn12tm1Vei Tg(Lck-cre)1Cwi)
decreased susceptibility to experimental autoimmune encephalomyelitis J:163910
Ptpn22tm1.1Draw/Ptpn22+
(involves: 129 * C57BL/6)
autoimmune response J:201448
increased anti-double stranded DNA antibody level J:201448
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
autoimmune response J:201448
increased anti-double stranded DNA antibody level J:201448
increased anti-insulin autoantibody level J:201448
Ptpn22tm2Achn/Ptpn22tm2Achn
Ptprctm1Weis/Ptprctm1Weis

(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn)
increased autoantibody level J:147129
Ptprctm1Weis/Ptprc+
(involves: 129X1/SvJ * C57BL/6)
increased anti-double stranded DNA antibody level J:66501
increased susceptibility to autoimmune disorder J:66501
Ptprctm1Weis/Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6)
increased anti-double stranded DNA antibody level J:66501
increased susceptibility to autoimmune disorder J:66501
Ptprntm1Aln/Ptprntm1Aln
(NOD.129S4-Ptprntm1Aln)
increased susceptibility to autoimmune diabetes J:107161
Ptprz1tm1Schl/Ptprz1tm1Schl
(involves: 129 * Swiss Webster)
increased susceptibility to experimental autoimmune encephalomyelitis J:79860
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6)
autoimmune response J:138466
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0

(NOD.Cg-Rag1tm1Mom Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs/Dvs)
increased susceptibility to autoimmune diabetes J:94192
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0

(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
increased susceptibility to autoimmune diabetes J:111874
Rag1tm1Mom/Rag1tm1Mom
Tnftm2Gkl/Tnf+

(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6)
rheumatoid arthritis J:54056
Rag2tm1.1Cgn/Rag2tm1.1Cgn
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0

(involves: C57BL/6 * DBA/2)
autoimmune response J:134764
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6)
increased susceptibility to systemic lupus erythematosus J:85189
Rasgrp1m1Anu/Rasgrp1+
(involves: C57BL/6JSfdAnu * CBA/J)
increased anti-nuclear antigen antibody level J:207898
Rasgrp1m1Anu/Rasgrp1m1Anu
(C57BL/6JSfdAnu-Rasgrp1m1Anu)
autoimmune response J:104190
Rasgrp1m1Anu/Rasgrp1m1Anu
(involves: C57BL/6JSfdAnu * CBA/J)
increased anti-nuclear antigen antibody level J:207898
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz)
increased autoantibody level J:225109
Rasgrp4tm1(cre)Rls/Rasgrp4tm1(cre)Rls
(C57BL/6-Rasgrp4tm1(cre)Rls)
decreased susceptibility to induced arthritis J:186519
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina)
increased anti-double stranded DNA antibody level J:168749
Rc3h1san/Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))
increased anti-double stranded DNA antibody level J:98938
increased anti-nuclear antigen antibody level J:98938
Reltm1Hcl/Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to autoimmune diabetes J:118907
decreased susceptibility to experimental autoimmune encephalomyelitis J:79107
Rftn1tm1Ayos/Rftn1tm1Ayos
(B6.Cg-Rftn1tm1Ayos)
decreased susceptibility to experimental autoimmune encephalomyelitis J:150299
Rnaseh2bem1Anu/Rnaseh2b+
Tlr7em2Anu/Tlr7+

(C57BL/6NCrl-Rnaseh2bem1Anu Tlr7em2Anu)
increased autoantibody level J:324448
Rnf128tm1Cdon/Rnf128+
(involves: 129 * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:160681
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: C57BL/6)
increased anti-double stranded DNA antibody level J:160681
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129 * C57BL/6)
increased anti-double stranded DNA antibody level J:160681
increased susceptibility to experimental autoimmune encephalomyelitis J:160681
Ro60tm1Woln/Ro60+
(involves: 129S1/Sv * C57BL/6)
increased anti-nuclear antigen antibody level J:84627
Ro60tm1Woln/Ro60tm1Woln
(involves: 129S1/Sv * C57BL/6)
increased anti-chromatin antibody level J:84627
increased anti-double stranded DNA antibody level J:84627
increased anti-histone antibody level J:84627
increased anti-nuclear antigen antibody level J:84627
increased anti-single stranded DNA antibody level J:84627
Rorctm1.1Zsun/Rorctm1.1Zsun
(B6(129S4)-Rorctm1.1Zsun)
decreased susceptibility to experimental autoimmune encephalomyelitis J:248565
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd)
decreased susceptibility to experimental autoimmune encephalomyelitis J:248565
Rpl13atm1.1Jesc/Rpl13atm1.1Jesc
(NOD.129S5(Cg)-Rpl13atm1.1Jesc)
decreased susceptibility to autoimmune diabetes J:237822
Rr17tm1.1Cdon/Rr17tm1.1Cdon
(involves: 129S6/SvEvTac * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:181186
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N)
increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Rxratm1Krc/Rxratm1Krc
Lyz2tm1(cre)Ifo/Lyz2+

(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
increased anti-double stranded DNA antibody level J:168799
increased anti-nuclear antigen antibody level J:168799
increased anti-single stranded DNA antibody level J:168799
increased autoantibody level J:168799
S1pr1tm1Jch/S1pr1tm1Jch
Tg(GFAP-cre)25Mes/?

(involves: C57BL/6J * FVB/N)
decreased susceptibility to experimental autoimmune encephalomyelitis J:168824
S1pr1tm1Jch/S1pr1tm1Jch
Tg(Nes-cre)1Kln/0

(involves: C57BL/6J * SJL)
decreased susceptibility to experimental autoimmune encephalomyelitis J:168824
Satb1tm2Kos/Satb1tm2Kos
Commd10Tg(Vav1-icre)A2Kio/Commd10+

(involves: C57BL/6 * C57BL/10 * CBA/Ca)
increased anti-nuclear antigen antibody level J:252606
increased autoantibody level J:252606
increased susceptibility to autoimmune disorder J:252606
Scara5tm1Ktry/Scara5tm1Ktry
(B6N.129X1-Scara5tm1Ktry)
increased anti-nuclear antigen antibody level J:195536
Scarf1tm1Tkms/Scarf1tm1Tkms
(involves: C57BL/6)
increased anti-histone antibody level J:208237
increased anti-nuclear antigen antibody level J:208237
increased anti-single stranded DNA antibody level J:208237
increased susceptibility to systemic lupus erythematosus J:208237
Secia1DBA/1J/?
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:123131
Secia2DBA/1J/?
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:123131
Secia3FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:123131
Secia4DBA/1J/?
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:123131
Secia5DBA/1J/?
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:123131
Secia6DBA/1J/?
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:123131
Secia7FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:123131
Secia8FVB/NJ/?
(involves: DBA/1J * FVB/NJ)
increased susceptibility to induced arthritis J:123131
Selltm1Flv/Sell+
(involves: C57BL/6 * NOD)
decreased susceptibility to autoimmune diabetes J:88947
Selltm1Flv/Selltm1Flv
(involves: C57BL/6 * NOD)
decreased susceptibility to autoimmune disorder J:88947
Selptm1Bay/Selptm1Bay
(D1.129S7(B6J)-Selptm1Bay)
increased susceptibility to induced arthritis J:57086
Senp1tm1Wami/Senp1tm1Wami
Tg(Fabp4-cre)#Abel/0

(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel)
increased anti-insulin autoantibody level J:228009
increased susceptibility to autoimmune diabetes J:228009
Shcbp1tm1c(EUCOMM)Wtsi/Shcbp1tm1c(EUCOMM)Wtsi
Tg(Lck-cre)1Cwi/?

(involves: C57BL/6 * DBA/2)
decreased susceptibility to experimental autoimmune encephalomyelitis J:212898
Shcbp1tm1d(EUCOMM)Wtsi/Shcbp1tm1d(EUCOMM)Wtsi
(involves: C57BL/6N * FVB/N)
decreased susceptibility to experimental autoimmune encephalomyelitis J:212898
Siglecgtm1Lnit/Siglecgtm1Lnit
(involves: BALB/c)
autoimmune response J:123353
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
increased anti-nuclear antigen antibody level J:160869
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ)
increased autoantibody level J:241633
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
increased susceptibility to experimental autoimmune encephalomyelitis J:100408
Skap2Gt(VICTR20)21Lex/Skap2Gt(VICTR20)21Lex
(B6.129S5-Skap2Gt(VICTR20)21Lex)
decreased susceptibility to experimental autoimmune encephalomyelitis J:101373
Slamf9em1Isha/Slamf9em1Isha
(involves: C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:279164
Slc1a5tm1Tac/Slc1a5tm1Tac
(involves: 129S/SvEv * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:254980
Slc5a2tm1Lex/Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
decreased susceptibility to autoimmune diabetes J:195941
Sle1NZW/Sle1NZW
Sles1NZW/Sles1NZW

(involves: C57BL/6 * NZW)
decreased susceptibility to systemic lupus erythematosus J:100678
Sle1NZW/Sle1NZW
Tg(Tnfsf13b)1Fma/0

(involves: C57BL/6 * DBA/2J * NZW)
increased susceptibility to systemic lupus erythematosus J:134128
Sle1aC57BL/6J/Sle1aNZM2410/J
(involves: C57BL/6J * NZM2410/J)
increased anti-chromatin antibody level J:67544
Sle1aNZM2410/J/Sle1aNZM2410/J
(involves: C57BL/6J * NZM2410/J)
increased anti-chromatin antibody level J:67544
Sle1bC57BL/6J/Sle1bNZM2410/J
(involves: C57BL/6J * NZM2410/J)
increased anti-chromatin antibody level J:67544
Sle1bNZM2410/J/Sle1bNZM2410/J
(involves: C57BL/6J * NZM2410/J)
increased anti-chromatin antibody level J:67544
Sle1cC57BL/6J/Sle1cNZM2410/J
(involves: C57BL/6J * NZM2410/J)
increased anti-chromatin antibody level J:67544
Sle1cNZB/Sle1cNZM2410/J
(involves: C57BL/6J * NZB * NZM2410/J)
increased autoantibody level J:145133
Sle1cNZM2410/J/Sle1cNZM2410/J
(involves: C57BL/6J * NZM2410/J)
increased anti-chromatin antibody level J:67544
Sle6NZW/Sle6NZW
(involves: C57BL/6 * NZW)
increased susceptibility to systemic lupus erythematosus J:57246
Sle9BXSB/J/Sle9BXSB/J
(involves: BXSB/J * C57BL/10Ola)
increased anti-nuclear antigen antibody level J:60445
Sle16129S6/SvEvTac/Sle16129S6/SvEvTac
(B6.129-Sle16129S6/SvEvTac)
increased autoantibody level J:122132
increased susceptibility to systemic lupus erythematosus J:122132
Sles1C57BL/6/Sles1C57BL/6
(involves: C57BL/6 * NZW)
increased susceptibility to systemic lupus erythematosus J:57246
Sles1NZW/Sles1NZW
(involves: C57BL/6 * NZW)
decreased susceptibility to systemic lupus erythematosus J:57246
Sles2C57BL/6/Sles2C57BL/6
(involves: C57BL/6 * NZW)
increased susceptibility to systemic lupus erythematosus J:57246
Sles2C57BL/6/Sles2NZW
(involves: C57BL/6 * NZW)
increased susceptibility to systemic lupus erythematosus J:57246
Sles2NZW/Sles2NZW
(involves: C57BL/6 * NZW)
decreased susceptibility to systemic lupus erythematosus J:57246
Sles3C57BL/6/Sles3C57BL/6
(involves: C57BL/6 * NZW)
increased susceptibility to systemic lupus erythematosus J:57246
Sles3C57BL/6/Sles3NZW
(involves: C57BL/6 * NZW)
increased susceptibility to systemic lupus erythematosus J:57246
Sles3NZW/Sles3NZW
(involves: C57BL/6 * NZW)
decreased susceptibility to systemic lupus erythematosus J:57246
Sles4C57BL/6/Sles4C57BL/6
(involves: C57BL/6 * NZW)
increased susceptibility to systemic lupus erythematosus J:57246
Sles4C57BL/6/Sles4NZW
(involves: C57BL/6 * NZW)
increased susceptibility to systemic lupus erythematosus J:57246
Sles4NZW/Sles4NZW
(involves: C57BL/6 * NZW)
decreased susceptibility to systemic lupus erythematosus J:57246
Slfn8tm1Aki/Slfn8tm1Aki
(involves: 129X1/SvJ * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:258797
Smad7tm1.1Ink/Smad7tm1.1Ink
Tg(Cd4-cre)1Cwi/0

(involves: C57BL/6 * DBA/2)
decreased susceptibility to experimental autoimmune encephalomyelitis J:184670
Socs1tm1.1Ayr/Socs1tm1.1Ayr
(involves: C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:226678
Socs1tm1Ayos/Socs1tm1Ayos
Tg(Lck-cre)1Jtak/0

(involves: 129S4/SvJae * C57BL/6)
decreased susceptibility to experimental autoimmune encephalomyelitis J:132905
Socs3tm1Robb/Socs3tm1Robb
(involves: C57BL/6)
increased susceptibility to induced arthritis J:145513
Sod3tm1Mrkl/Sod3tm1Mrkl
(D1.129P2-Sod3tm1Mrkl)
increased susceptibility to induced arthritis J:106273
Spink14tm1e(KOMP)Wtsi/Spink14tm1e(KOMP)Wtsi
(C57BL/6N-Spink14tm1e(KOMP)Wtsi/Wtsi)
increased anti-nuclear antigen antibody level J:211773
Spntm1Bam/Spntm1Bam
(B6;129S4-Spntm1Bam/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:86932
Spp1tm1Blh/Spp1tm1Blh
(B6.129S6-Spp1tm1Blh)
decreased susceptibility to experimental autoimmune uveoretinitis J:116272
St14tm2Bug/St14tm3Bug
Tg(MMTV-cre)4Mam/0

(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss)
increased anti-nuclear antigen antibody level J:213072
increased autoantibody level J:213072
Stat4tm1Gru/Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru)
decreased susceptibility to autoimmune diabetes J:90600
Stat4tm1Gru/Stat4tm1Gru
Tg(Ins2-GP)34-20Olds/0

(involves: 129S2/SvPas * BALB/c * C57BL/6)
abnormal susceptibility to autoimmune disorder J:107047
Stat4tm1Gru/Stat4tm1Gru
Tg(Ins2-NP)25-3Olds/0

(involves: 129S2/SvPas * BALB/c * C57BL/6)
decreased susceptibility to autoimmune diabetes J:107047
Stat4tm1Jni/Stat4tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
decreased susceptibility to autoimmune diabetes J:96338
Stat4tm1Jni/Stat4tm1Jni
Stat6tm1Jni/Stat6tm1Jni

(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
increased susceptibility to autoimmune diabetes J:96338
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6)
decreased susceptibility to autoimmune diabetes J:96338
Stim1tm1Kuro/Stim1tm1Kuro
Stim2tm1.1Kuro/Stim2tm1.1Kuro
Cd79atm1(cre)Reth/Cd79a+

(involves: BALB/c * C57BL/6)
increased susceptibility to experimental autoimmune encephalomyelitis J:172608
Stk17btm1Hed/Stk17btm1Hed
(B6.129X1-Stk17btm1Hed)
decreased susceptibility to experimental autoimmune encephalomyelitis J:94685
Swap70tm1Jess/Swap70tm1Jess
(involves: 129T2/SvEms * 129X1/SvJ)
increased autoantibody level J:71160
Swrl2SWR/Swrl2SWR
(involves: NZB * SWR)
increased anti-single stranded DNA antibody level J:96060
Swrl3NZB/Swrl3SWR
(involves: NZB * SWR)
increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96060
increased anti-nuclear antigen antibody level J:73097
Swrl3SWR/Swrl3SWR
(involves: NZB * SWR)
increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96060
increased anti-nuclear antigen antibody level J:73097
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
increased anti-insulin autoantibody level J:188422
Syt7tm1Nan/Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6)
increased anti-nuclear antigen antibody level J:85201
increased susceptibility to autoimmune disorder J:85201
Syvn1tm1Tn/Syvn1+
(D1.Cg-Syvn1tm1Tn)
decreased susceptibility to induced arthritis J:86009
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * C57BL/6)
increased anti-double stranded DNA antibody level J:151757
increased anti-nuclear antigen antibody level J:151757
Tap1tm1Arp/Tap1tm1Arp
X/Yaa

(BXSB.129S2(B6)-Tap1tm1Arp/Dcr)
increased susceptibility to systemic lupus erythematosus J:179430
Tarm1tm1Yiw/Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc)
decreased susceptibility to induced arthritis J:301164
Tbc1d10ctm1.1Psou/Tbc1d10ctm1.2Psou
Cd79atm1(cre)Reth/Cd79a+

(involves: 129S2/SvPas * BALB/c * C57BL/6J)
increased anti-double stranded DNA antibody level J:211913
increased susceptibility to systemic lupus erythematosus J:211913
Tbc1d10ctm1.2Psou/Tbc1d10ctm1.2Psou
(involves: 129S2/SvPas * C57BL/6J)
increased anti-double stranded DNA antibody level J:211913
increased susceptibility to systemic lupus erythematosus J:211913
Tbk1tm1Arte/Tbk1tm1Arte
Cd19tm1(cre)Cgn/Cd19+

(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
increased anti-double stranded DNA antibody level J:188560
increased anti-nuclear antigen antibody level J:188560
Tbx21tm1Glm/Tbx21tm1Glm
(C.129S6-Tbx21tm1Glm/J)
decreased susceptibility to experimental autoimmune encephalomyelitis J:111932
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi)
decreased susceptibility to induced arthritis J:99107
Tcratm1Mjo/Tcra+
(